var title_f5_22_5472="Mastectomy skin flap development";
var content_f5_22_5472=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=SURG%2F50156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=SURG%2F50156&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 546px\">",
"   <div class=\"ttl\">",
"    Mastectomy skin flap development",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 526px; height: 387px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Development of the skin ���������aps proceeds with retraction of the skin at a right angle to the table. With traction on the breast tissue, pressing down or pulling away from the skin ���������ap, the tissue plane is more readily identi���������able. The plane between the adipose of the skin and that of the breast is usually found 2 to 4 mm below the dermis. The adipose of the skin is the thinnest near the areola and slowly becomes thicker toward the chest wall. Adair breast tenaculae are depicted here in the retraction, but other methods are utilized as well.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Shaughnessy EA. Simple mastectomy. In: Master Techniques in General Surgery: Breast Surgery, Bland KI, Klimberg SV (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2011. Copyright &copy; 2011 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5472=[""].join("\n");
var outline_f5_22_5472=null;
var title_f5_22_5473="Nocardia mycetoma-like lesion";
var content_f5_22_5473=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54114&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mycetoma-like lesion caused by Nocardia asteroides",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 396px; height: 257px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This lesion of the hand and arm was caused by Nocardia asteroides.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Lee T Nesbitt, Jr, MD. Reproduced with permission from The Skin and Infection: A Color Atlas and Text. Sanders CV, Nesbitt LT Jr (Eds) Lippincott Williams &amp; Wilkins, Baltimore 1995. p.60.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5473=[""].join("\n");
var outline_f5_22_5473=null;
var title_f5_22_5474="Application of tissue adhesive";
var content_f5_22_5474=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F82996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F82996&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Application of tissue adhesive to a superficial laceration",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 363px; height: 427px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    The wound edges are held in apposition with the fingers of the nondominant hand, and adhesive is applied evenly across the entire wound, including a margin of at least 5 to 10 mm on either side of the wound. The left-lower panel depicts incorrect placement of adhesive into the wound, which should be avoided.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Hollander JE. Use of tissue adhesives in laceration repair. In: Textbook of Pediatric Emergency Procedures, 2nd edition, King C, Henretig FM (Eds), Lippincott Williams &amp; Wilkins, 2008. Copyright &copy; 2008 Lippincott Williams &amp; Wilkins.",
"    </div>",
"    <div class=\"contractual\">",
"     <br/>",
"     <a href=\"file://www.lww.com\">",
"      file://www.lww.com",
"     </a>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5474=[""].join("\n");
var outline_f5_22_5474=null;
var title_f5_22_5475="Patient information: Human papillomavirus (HPV) vaccine (The Basics)";
var content_f5_22_5475=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div>",
"   &nbsp;",
"  </div>",
"  <div id=\"basicsTopicMinWidth\">",
"   <div id=\"basicsTopicRight\">",
"    <div id=\"placeholder\">",
"     <div id=\"basics-graphics\">",
"      <span class=\"basics-box-top\">",
"      </span>",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-graphics-title.png\"/>",
"       <span class=\"openRelatedGraphics\" id=\"PI/15743\" rel=\"graphic_box\">",
"        <a href=\"#\" title=\"View All Related Graphics\">",
"         View All",
"        </a>",
"       </span>",
"      </h4>",
"      <ul>",
"       <li>",
"        <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"         Female reproductive anatomy",
"        </a>",
"       </li>",
"      </ul>",
"      <a href=\"#\" id=\"basics-seeall\">",
"       See All Graphics",
"      </a>",
"     </div>",
"     <script type=\"text/javascript\">",
"      if ($(\"#basics-graphics li\").length &lt;= 4) {",
"				$(\"#basics-seeall\").remove();",
"			} else {",
"				$(\"#basics-graphics li:gt(3)\").addClass(\"hidden\");",
"				$(\"#basics-seeall\").click(function(){",
"					$(\"#basics-graphics li.hidden\").removeClass(\"hidden\");",
"					$(this).remove();",
"					return false;",
"				});",
"			}",
"     </script>",
"     <div class=\"ieSpacer\">",
"     </div>",
"     <div id=\"basics-more\">",
"      <h4>",
"       <img src=\"file://www.uptodate.com/images/basics-more-title.png\"/>",
"      </h4>",
"      <dl>",
"       <dt class=\"basics\">",
"        The Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?27/32/28163\">",
"         Patient information: Cervical cancer (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?13/56/14211\">",
"         Patient information: Choosing birth control (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?16/13/16594\">",
"         Patient information: Genital warts (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?11/48/12035\">",
"         Patient information: Vaccines (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?23/4/23619\">",
"         Patient information: Vaccines for adults (The Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?18/7/18547\">",
"         Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"        </a>",
"       </dd>",
"       <dt class=\"beyondthebasics\">",
"        Beyond the Basics",
"       </dt>",
"       <dd>",
"        <a href=\"UTD.htm?38/25/39318\">",
"         Patient information: Adult vaccines (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?7/53/8019\">",
"         Patient information: Cervical cancer screening (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?15/4/15429\">",
"         Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?3/60/4035\">",
"         Patient information: Genital warts in women (Beyond the Basics)",
"        </a>",
"       </dd>",
"       <dd>",
"        <a href=\"UTD.htm?37/45/38610\">",
"         Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)",
"        </a>",
"       </dd>",
"      </dl>",
"      <div id=\"tooltipper\">",
"      </div>",
"     </div>",
"    </div>",
"   </div>",
"   <div id=\"basicsTopicLeft\">",
"    <div id=\"topicTitle\">",
"     Patient information: Human papillomavirus (HPV) vaccine (The Basics)",
"    </div>",
"    <span class=\"view\">",
"     View in",
"     <a class=\"lang\" href=\"./es-419/human-papillomavirus-hpv-vaccine-the-basics?source=topic_page\">",
"      Spanish",
"     </a>",
"    </span>",
"    <a class=\"contributor contributor_credentials\" href=\"./authors-and-editors/patient-information\">",
"     Written by the doctors and editors at UpToDate",
"    </a>",
"    <div id=\"topicText\">",
"     <p class=\"headingAnchor\" id=\"H2216790\">",
"      <span class=\"h1\">",
"       What is the human papillomavirus (HPV) vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The HPV vaccine helps keep people from getting infected with a germ called &ldquo;human papillomavirus,&rdquo; or &ldquo;HPV.&rdquo;",
"     </p>",
"     <p>",
"      Vaccines are treatments that can prevent infections. They work by preparing the body to fight the germs that cause the infections. Vaccines usually come in shots, but some come in nose sprays or medicines that people swallow. Vaccines are also called &ldquo;vaccinations&rdquo; or &ldquo;immunizations.&rdquo;",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216797\">",
"      <span class=\"h1\">",
"       Why should I get the HPV vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The HPV vaccine can help keep you from getting an HPV infection. An HPV infection can lead to cancer of the cervix (cervical cancer) in women (",
"      <a class=\"graphic graphic_figure graphicRef80271 \" href=\"UTD.htm?14/52/15171\">",
"       figure 1",
"      </a>",
"      ). An HPV infection can also cause genital warts in women and men.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216804\">",
"      <span class=\"h1\">",
"       How can people get infected with HPV?",
"      </span>",
"      &nbsp;&mdash;&nbsp;People can get infected with HPV if they have sex with or touch the genitals of someone who is infected. People who have a lot of sex partners have a higher chance of getting an HPV infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216811\">",
"      <span class=\"h1\">",
"       What are the symptoms of an HPV infection?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most people do not have any symptoms when they get infected with HPV. And often, the infection will get better on its own. But in some people, the infection doesn&rsquo;t go away. People with a long-lasting HPV infection have a higher chance of getting cervical cancer or genital warts. These problems usually happen many years after a person is first infected.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216818\">",
"      <span class=\"h1\">",
"       Are different HPV vaccines available?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes, 2 different HPV vaccines are available. Girls and women can get either vaccine. Boys and men only get one type of HPV vaccine. Both HPV vaccines come in shots. Both involve getting 3 doses over 6 months.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216825\">",
"      <span class=\"h1\">",
"       At what age do people get the HPV vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Most doctors recommend that girls get the HPV vaccine at age 11 or 12. But girls and women can get the vaccine any time from age 9 to 26. Women should not get the vaccine if they are pregnant. Boys can get the vaccine any time from age 9 to 26.",
"     </p>",
"     <p>",
"      The HPV vaccine works best when it is given before a person gets infected with HPV. The HPV vaccine can&rsquo;t cure an HPV infection that a person already has. That&rsquo;s why it is better to get the HPV vaccine before you have sex for the first time. If you have already had sex, talk with your doctor or nurse. He or she might recommend that you get the HPV vaccine anyway, because it could still help you.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216832\">",
"      <span class=\"h1\">",
"       What side effects can the HPV vaccine cause?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The HPV vaccine can cause redness, swelling, or soreness where the shot was given. It can also cause people to pass out, but this is uncommon. To make sure that this doesn&rsquo;t happen, your doctor or nurse will have you stay on the exam table for a few minutes after the shot.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216839\">",
"      <span class=\"h1\">",
"       Does the HPV vaccine always work?",
"      </span>",
"      &nbsp;&mdash;&nbsp;The HPV vaccine is very good at preventing HPV infection and cervical cancer. But it is not perfect. In some cases, people who get the vaccine can still get an HPV infection.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216846\">",
"      <span class=\"h1\">",
"       Does the HPV vaccine prevent other diseases from sex?",
"      </span>",
"      &nbsp;&mdash;&nbsp;No. The HPV vaccine does not keep people from getting or spreading other diseases that are spread through sex. To keep from getting or spreading a disease that is spread through sex, you should use a type of protection called a condom.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216853\">",
"      <span class=\"h1\">",
"       Do I need to be checked for cervical cancer if I get the vaccine?",
"      </span>",
"      &nbsp;&mdash;&nbsp;Yes. All women, including those who get the HPV vaccine, should be checked on a routine schedule for cervical cancer. Most women are checked using a test called a &ldquo;pap smear&rdquo; starting at age 21 or within 3 years of having sex for the first time.",
"     </p>",
"     <p class=\"headingAnchor\" id=\"H2216860\">",
"      <span class=\"h1\">",
"       More on this topic",
"      </span>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?11/48/12035?source=see_link\">",
"       Patient information: Vaccines (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=see_link\">",
"       Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23619?source=see_link\">",
"       Patient information: Vaccines for adults (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?16/13/16594?source=see_link\">",
"       Patient information: Genital warts (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28163?source=see_link\">",
"       Patient information: Cervical cancer (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?13/56/14211?source=see_link\">",
"       Patient information: Choosing birth control (The Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=see_link\">",
"       Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=see_link\">",
"       Patient information: Adult vaccines (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?7/53/8019?source=see_link\">",
"       Patient information: Cervical cancer screening (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=see_link\">",
"       Patient information: Genital warts in women (Beyond the Basics)",
"      </a>",
"     </p>",
"     <p>",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?15/4/15429?source=see_link\">",
"       Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)",
"      </a>",
"     </p>",
"    </div>",
"    <div id=\"reviewProcess\">",
"     <span>",
"      All topics are updated as new evidence becomes available and our",
"      <a class=\"policy policy_editorialpolicy\" href=\"/home/editorial-policy\">",
"       peer review process",
"      </a>",
"      is complete.",
"     </span>",
"    </div>",
"    <div id=\"topicRetrievedDate\">",
"     <span class=\"emphasis\">",
"      This topic retrieved from UpToDate on:",
"     </span>",
"     Apr 20, 2013.",
"    </div>",
"    <div class=\"patTopicTool\" id=\"patTopicToolBottom\">",
"     <a class=\"toolbutton findicon findInPageLink\" href=\"#\" title=\"Find in Topic\">",
"      Find",
"     </a>",
"     <a class=\"toolbutton printicon\" href=\"UTD.htm?5/22/5475?view=print\" title=\"Print This Topic\">",
"      Print",
"     </a>",
"     <a class=\"toolbutton emailicon etacLink\" href=\"#\" title=\"Email This Topic\">",
"      Email",
"     </a>",
"    </div>",
"    <div id=\"disclaimer\">",
"     The content on the UpToDate website is not intended nor recommended as a substitute for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or other qualified health care professional regarding any medical questions or conditions.",
"The use of UpToDate content is governed by the",
"     <a class=\"legal legal_termsofuse\" href=\"/home/terms-use\" target=\"_blank\">",
"      UpToDate Terms of Use",
"     </a>",
"     . &copy;2013 UpToDate, Inc. All rights reserved.",
"    </div>",
"    <div id=\"topicVersionRevision\">",
"     Topic 15743 Version 2.0",
"    </div>",
"   </div>",
"   <!--  basicsTopicLeft -->",
"  </div>",
"  <!-- basicsTopicMinWidth -->",
" </div>",
" <!-- topicContent -->",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0602-115.25.216.6-BADE3B5A5F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5475=[""].join("\n");
var outline_f5_22_5475=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216790\">",
"      What is the human papillomavirus (HPV) vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216797\">",
"      Why should I get the HPV vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216804\">",
"      How can people get infected with HPV?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216811\">",
"      What are the symptoms of an HPV infection?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216818\">",
"      Are different HPV vaccines available?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216825\">",
"      At what age do people get the HPV vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216832\">",
"      What side effects can the HPV vaccine cause?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216839\">",
"      Does the HPV vaccine always work?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216846\">",
"      Does the HPV vaccine prevent other diseases from sex?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216853\">",
"      Do I need to be checked for cervical cancer if I get the vaccine?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2216860\">",
"      More on this topic",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"PI/15743\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li>",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?14/52/15171\">",
"      Female reproductive anatomy",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?38/25/39318?source=related_link\">",
"      Patient information: Adult vaccines (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?27/32/28163?source=related_link\">",
"      Patient information: Cervical cancer (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?7/53/8019?source=related_link\">",
"      Patient information: Cervical cancer screening (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?15/4/15429?source=related_link\">",
"      Patient information: Cervical cancer treatment; early stage cancer (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?13/56/14211?source=related_link\">",
"      Patient information: Choosing birth control (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?16/13/16594?source=related_link\">",
"      Patient information: Genital warts (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?3/60/4035?source=related_link\">",
"      Patient information: Genital warts in women (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?37/45/38610?source=related_link\">",
"      Patient information: Human papillomavirus (HPV) vaccine (Beyond the Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?11/48/12035?source=related_link\">",
"      Patient information: Vaccines (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?23/4/23619?source=related_link\">",
"      Patient information: Vaccines for adults (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?18/7/18547?source=related_link\">",
"      Patient information: Vaccines for children age 7 to 18 years (The Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_22_5476="Mitral valve structure";
var content_f5_22_5476=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F79932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F79932&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 554px\">",
"   <div class=\"ttl\">",
"    Mitral valve structure",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 534px; height: 497px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5476=[""].join("\n");
var outline_f5_22_5476=null;
var title_f5_22_5477="Ferrous sulfate: Patient drug information";
var content_f5_22_5477=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Ferrous sulfate: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?36/11/37046?source=see_link\">",
"     see \"Ferrous sulfate: Drug information\"",
"    </a>",
"    and",
"    <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/62/15334?source=see_link\">",
"     see \"Ferrous sulfate: Pediatric drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F170907\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Feosol&reg; [OTC];",
"     </li>",
"     <li>",
"      Fer-In-Sol&reg; [OTC];",
"     </li>",
"     <li>",
"      Fer-iron [OTC];",
"     </li>",
"     <li>",
"      MyKidz Iron 10&trade; [OTC];",
"     </li>",
"     <li>",
"      Slow FE&reg; [OTC];",
"     </li>",
"     <li>",
"      Slow Release [OTC]",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F170908\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Apo-Ferrous Sulfate&reg;;",
"     </li>",
"     <li>",
"      Fer-In-Sol&reg;;",
"     </li>",
"     <li>",
"      Ferodan&trade;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10019355\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Accidental overdose of drugs that have iron in them is a leading cause of deadly poisoning in children younger than 6 years of age. Keep away from children. If this drug is taken by accident, call a doctor or poison control center right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10019357\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691725",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat anemia.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691235",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Iron is most often taken during pregnancy to stop anemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10019356\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2702118",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to ferrous sulfate or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703226",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any of these health problems: Anemia from a cause other than low iron stores, too much iron in your body, or thalassemia.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10019361\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696857",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take calcium, zinc, copper, or multivitamins that have any of these minerals within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696833",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take antacids within 2 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696904",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take tetracycline within 4 hours of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697607",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take antibiotics like ciprofloxacin and levofloxacin 2 hours before this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697641",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are pregnant or plan on getting pregnant. You will need to talk about the benefits and risks of using this drug while you are pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697636",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you are breast-feeding. You will need to talk about any risks to your baby.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10019362\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697891",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Belly pain.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697978",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Hard stools (constipation). Drinking more liquids, working out, or adding fiber to your diet may help. Talk with your doctor about a stool softener or laxative.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697895",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Black stools.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10019364\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699019",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very loose stools (diarrhea).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699014",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very hard stools (constipation).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698681",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If a child eats your tablets. Poisonings with iron happen most often in children. First signs of overdose include feeling tired, upset stomach, throwing up, belly pain, dark tarry-black stool, and a weak or fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, period changes. These include lots of bleeding, spotting, or bleeding between cycles.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10019359\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695812",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take 1 hour before or 2 hours after bran, fiber, tea, coffee, dairy products, or eggs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695322",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Long-acting products: Swallow whole. Do not chew, break, or crush.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695407",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Mix liquid with water or juice and drink it from a straw for less stains on your teeth. Rinse your mouth.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694866",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10019360\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10019365\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10019366\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 12469 Version 37.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0605-83.177.194.223-190351C039-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5477=[""].join("\n");
var outline_f5_22_5477=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F170907\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F170908\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019355\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019357\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019356\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019361\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019362\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019364\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019359\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019360\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019365\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10019366\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?36/11/37046?source=related_link\">",
"      Ferrous sulfate: Drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?14/62/15334?source=related_link\">",
"      Ferrous sulfate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_22_5478="Amlodipine, valsartan, and hydrochlorothiazide: Patient drug information";
var content_f5_22_5478=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"2\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"disclaimer\">",
"   The content on the UpToDate website is not intended nor recommended as a substitute",
"for medical advice, diagnosis, or treatment.  Always seek the advice of your own physician or",
"other qualified health care professional regarding any medical questions or conditions.  The",
"use of this website is governed by the",
"   <a href=\"/home/terms-use\" target=\"_blank\">",
"    UpToDate Terms of Use",
"   </a>",
"   &copy;2013 UpToDate, Inc.",
"  </div>",
"  <div id=\"drugTitle\">",
"   Amlodipine, valsartan, and hydrochlorothiazide: Patient drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   <p>",
"    (For additional information",
"    <a class=\"drug drug_general\" href=\"UTD.htm?17/53/18264?source=see_link\">",
"     see \"Amlodipine, valsartan, and hydrochlorothiazide: Drug information\"",
"    </a>",
"    )",
"   </p>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F7742345\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Exforge HCT&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt war-os drugH1Div\" id=\"F10017645\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warning",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700281",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take if you are pregnant. Use during pregnancy may cause birth defects or loss of the unborn baby. If you get pregnant or plan on getting pregnant while taking this drug, call your doctor right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2700602",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sometimes drugs are not safe when you take them with certain other drugs. Taking them together can cause bad side effects. This is one of those drugs. Be sure to talk to your doctor about all the drugs you take.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yya-os drugH1Div\" id=\"F10017647\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What is this drug used for?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691888",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to treat high blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2691367",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       It is used to get rid of extra fluid.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt coi-os drugH1Div\" id=\"F10017646\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I need to tell my doctor before I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701507",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have an allergy to amlodipine, valsartan, hydrochlorothiazide, or any other part of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2705171",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are allergic to any drugs, foods, or other substances. Tell your doctor about the allergy and what signs you had, like rash; hives; itching; shortness of breath; wheezing; cough; swelling of face, lips, tongue, or throat; or any other signs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701385",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a sulfa (sulfonamide) allergy, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2703719",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have a block in the kidneys' arteries or other kidney disease.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s3915366",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes) and are taking aliskiren.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701080",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are pregnant or may be pregnant.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2701047",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are breast-feeding.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yye-os drugH1Div\" id=\"F10017651\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some things I need to know or do while I take this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697780",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Wear disease medical alert ID (identification).",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696820",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not run out of this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697207",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have high blood sugar (diabetes), this drug may sometimes raise blood sugar. Talk with your doctor about how to fine tune this.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697290",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have liver disease, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698416",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood pressure and heart rate checked often. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698465",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Have your blood work checked. Talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696717",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Check all drugs you are taking with your doctor. This drug may not mix well with some other drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697100",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you are taking a salt substitute that has potassium, potassium-sparing diuretics, or potassium, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697627",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with your doctor before using OTC products that may raise blood pressure. These include cough or cold drugs, diet pills, stimulants, ibuprofen or like products, and some natural products or aids.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697562",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Limit your drinking of wine, beer, or mixed drinks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s4128402",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you drink grapefruit juice or eat grapefruit often, talk with your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697788",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       You may get sunburned more easily. Avoid sun, sunlamps, and tanning beds. Use sunscreen and wear clothing and eyewear that protects you from the sun.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696701",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Be careful in hot weather. Drink lots of fluids to stop fluid loss.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697779",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Watch for gout attacks.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697740",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Use birth control that you can trust to stop pregnancy while taking this drug.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyf-os drugH1Div\" id=\"F10017652\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects of this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698051",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Feeling dizzy. Rise slowly over a few minutes when sitting or lying down. Be careful climbing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698148",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       High potassium level. Signs include feeling weak, lightheaded, dizzy, feel like passing out, or have numbness or tingling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698217",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium levels like muscle pain or weakness, muscle cramps, or a heartbeat that does not feel normal.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698119",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698364",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Swelling.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2697983",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698272",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Upset stomach or throwing up. Many small meals, good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698027",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Dry mouth. Good mouth care, sucking hard, sugar-free candy, or chewing sugar-free gum may help. See a dentist often.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698395",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Kidney function that gets worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyh-os drugH1Div\" id=\"F10017654\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What are some side effects that I need to call my doctor about right away?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698721",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you think there has been an overdose, call 1-800-222-1222 (the American Association of Poison Control Centers), your local poison control center (file://www.aapcc.org), or emergency room (ER) right away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699066",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of an allergic reaction, like rash; hives; itching; red, swollen, blistered, or peeling skin with or without fever; wheezing; tightness in the chest or throat; trouble breathing or talking; unusual hoarseness; or swelling of the mouth, face, lips, tongue, or throat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698655",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       A fast heartbeat.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699023",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad dizziness or passing out.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698640",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Trouble breathing.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699031",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very bad headache.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699042",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Very upset stomach or throwing up.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699070",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of high potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699072",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Signs of low potassium.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698998",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Cough that does not go away.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698650",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Tell your doctor if you have too much sweat, fluid loss, throwing up, or loose stools. This may lead to low blood pressure.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699104",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Not able to pass urine.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699086",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Sudden change in eyesight, eye pain, or irritation.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698670",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       For women, if you get pregnant while taking this drug.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698603",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Any rash.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2698977",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Side effect or health problem is not better or you are feeling worse.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyc-os drugH1Div\" id=\"F10017649\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How is this drug best taken?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695786",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take as you have been told, even if you feel well.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695852",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take this drug at the same time of day.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695872",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       This drug may cause you to pass urine more often. To keep from having sleep problems, try to take before 6 pm.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2695914",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take with or without food. Take with food if it causes an upset stomach.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2694865",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Follow the diet and workout plan that your doctor told you about.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyd-os drugH1Div\" id=\"F10017650\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     What do I do if I miss a dose?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696563",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Take a missed dose as soon as you think about it.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696496",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If it is close to the time for your next dose, skip the missed dose and go back to your normal time.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696475",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not take 2 doses at the same time or extra doses.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2696457",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not change the dose or stop this drug. Talk with the doctor.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyi-os drugH1Div\" id=\"F10017655\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     How do I store and/or throw out this drug?",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699336",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store at room temperature.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b498:s2699266",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Store in a dry place. Do not store in a bathroom.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ord-stmt yyj-os drugH1Div\" id=\"F10017656\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     General drug facts",
"    </span>",
"    <ul class=\"statements\" style=\"list-style-type:none;\">",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699675",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If your symptoms or health problems do not get better or if they become worse, call your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699673",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Do not share your drugs with others and do not take anyone else's drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699678",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep all drugs out of the reach of children and pets.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699709",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       If you have any questions about this drug, please talk with your doctor, pharmacist, or other health care provider.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s3302581",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       In Canada, take any unused drugs to the pharmacy. Also, visit file://www.hc-sc.gc.ca/hl-vs/iyh-vsv/med/disposal-defaire-eng.php#th to learn about the right way to get rid of unused drugs.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699677",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Keep a list of all your drugs (prescription, natural products, vitamins, OTC) with you. Give this list to your doctor.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699671",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       These are not all of the side effects that may occur. If you have questions about side effects, call your doctor. Call your doctor for medical advice about side effects.",
"      </span>",
"     </li>",
"     <li class=\"statement\">",
"      <span class=\"attributes\" style=\"display:none;\">",
"       <span class=\"entity\">",
"        &bull;",
"       </span>",
"       <span class=\"link\">",
"        urn:lims:b259:s2699683",
"       </span>",
"      </span>",
"      <span class=\"content\">",
"       Talk with the doctor before starting any new drug, including prescription or OTC, natural products, or vitamins.",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 11056 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0603-122.72.76.133-52D7E7C181-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5478=[""].join("\n");
var outline_f5_22_5478=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7742345\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017645\">",
"      Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017647\">",
"      What is this drug used for?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017646\">",
"      What do I need to tell my doctor before I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017651\">",
"      What are some things I need to know or do while I take this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017652\">",
"      What are some side effects of this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017654\">",
"      What are some side effects that I need to call my doctor about right away?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017649\">",
"      How is this drug best taken?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017650\">",
"      What do I do if I miss a dose?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017655\">",
"      How do I store and/or throw out this drug?",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F10017656\">",
"      General drug facts",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_general\" href=\"UTD.htm?17/53/18264?source=related_link\">",
"      Amlodipine, valsartan, and hydrochlorothiazide: Drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_22_5479="Mucoepidermoid CT";
var content_f5_22_5479=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F56018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F56018&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Mucoepidermoid carcinoma of the trachea",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 390px; height: 454px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Computed tomographic scan demonstrates tracheal lesion and paramediastinal lung fibrosis from previous radiation therapy for invasive thymoma. Histology demonstrates a mixture of mucin-producing columnar cells, epidermoid (squamous) cells, and polygonal intermediate cells.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5479=[""].join("\n");
var outline_f5_22_5479=null;
var title_f5_22_5480="Sodium phosphate: Drug information";
var content_f5_22_5480=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"0\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Sodium phosphate: Drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   (For additional information",
"   <a class=\"drug drug_patient\" href=\"UTD.htm?19/15/19702?source=see_link\">",
"    see \"Sodium phosphate: Patient drug information\"",
"   </a>",
"   and",
"   <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/47/36599?source=see_link\">",
"    see \"Sodium phosphate: Pediatric drug information\"",
"   </a>",
"   )",
"   <br/>",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"block black-box-warn drugH1Div\" id=\"F7688983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     ALERT: U.S. Boxed Warning",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     The FDA-approved labeling includes a boxed warning. See Warnings/Precautions section for a concise summary of this information.  For verbatim wording of the boxed warning, consult the product labeling or",
"     <a href=\"file://www.fda.gov\" target=\"_blank\">",
"      www.fda.gov",
"     </a>",
"     .",
"    </p>",
"   </div>",
"   <div class=\"list ubnlist drugH1Div drugBrandNames\" id=\"F221976\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: U.S.",
"    </span>",
"    <ul>",
"     <li>",
"      Fleet&reg; Enema Extra&reg; [OTC];",
"     </li>",
"     <li>",
"      Fleet&reg; Enema [OTC];",
"     </li>",
"     <li>",
"      Fleet&reg; Pedia-Lax&trade; Enema [OTC];",
"     </li>",
"     <li>",
"      LaCrosse Complete [OTC];",
"     </li>",
"     <li>",
"      OsmoPrep&reg;;",
"     </li>",
"     <li>",
"      Visicol&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list cbnlist drugH1Div drugBrandNames\" id=\"F221977\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Brand Names: Canada",
"    </span>",
"    <ul>",
"     <li>",
"      Fleet Enema&reg;",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"ex_sect_xr thclist drugH1Div drugBrandNames\" id=\"F221989\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      Cathartic;",
"     </li>",
"     <li>",
"      Electrolyte Supplement, Parenteral;",
"     </li>",
"     <li>",
"      Laxative, Bowel Evacuant",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block doa drugH1Div\" id=\"F221980\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Adult",
"    </span>",
"    <p style=\"text-indent:0em;margin-left:0em;margin-top:0em;text-align:justify;display:inline\">",
"     <b>",
"      Caution: With orders for I.V. phosphate, there is considerable confusion associated with the use of millimoles (mmol) versus milliequivalents (mEq) to express the phosphate requirement.",
"     </b>",
"     The most reliable method of ordering I.V. phosphate is by millimoles, then specifying the potassium or sodium salt. Intravenous doses listed as mmol of phosphate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Acute treatment of hypophosphatemia:",
"     </b>",
"     I.V.: It is difficult to provide concrete guidelines for the treatment of severe hypophosphatemia because the extent of total body deficits and response to therapy are difficult to predict. Aggressive doses of phosphate may result in a transient serum elevation followed by redistribution into intracellular compartments or bone tissue. It is recommended that repletion of severe hypophosphatemia be done I.V. because large doses of oral phosphate may cause diarrhea and intestinal absorption may be unreliable. Intermittent I.V. infusion should be reserved for severe depletion situations; requires continuous cardiac monitoring. Guidelines differ based on degree of illness, need/use of TPN, and severity of hypophosphatemia. If hypokalemia exists (some clinicians recommend threshold of &lt;4 mmol/L), consider phosphate replacement strategy with potassium (eg, potassium phosphates). Obese patients and/or severe renal impairment were excluded from phosphate supplement trials.",
"     <b>",
"      Note:",
"     </b>",
"     1 mmol phosphate = 31 mg phosphorus; 1 mg phosphorus = 0.032 mmol phosphate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      General replacement guidelines (Lentz, 1978):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Low dose, serum phosphorus losses are recent and uncomplicated: 0.08 mmol/kg over 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intermediate dose, serum phosphorus level 0.5-1 mg/dL (0.16-0.32 mmol/L): 0.16-0.24 mmol/kg over 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     The initial dose may be increased by 25% to 50% if the patient is symptomatic secondary to hypophosphatemia and lowered by 25% to 50% if the patient is hypercalcemic.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Critically-ill adult patients receiving concurrent enteral/parenteral nutrition (Brown, 2006; Clark, 1995):",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     Round doses to the nearest 7.5 mmol for ease of preparation. If administering with phosphate-containing parenteral nutrition, do not exceed 15 mmol/L within parenteral nutrition. May use adjusted body weight for patients weighing &gt;130% of ideal body weight (and BMI &lt;40 kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ) by using [IBW + 0.25 (ABW-IBW)]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Low dose, serum phosphorus level 2.3-3 mg/dL (0.74-0.96 mmol/L): 0.16-0.32 mmol/kg over 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intermediate dose, serum phosphorus level 1.6-2.2 mg/dL (0.51-0.71 mmol/L): 0.32-0.64 mmol/kg over 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     High dose, serum phosphorus &lt;1.5 mg/dL (&lt;0.5 mmol/L): 0.64-1 mmol/kg over 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Parenteral nutrition:",
"     </b>",
"     I.V.: 10-15 mmol/1000 kcal (Hicks, 2001)",
"     <b>",
"      or",
"     </b>",
"     20-40 mmol/24 hours (Mirtallo, 2004 [ASPEN guidelines])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Laxative (Fleet&reg;):",
"     </b>",
"     Rectal: Contents of one 4.5 oz enema as a single dose",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Laxative:",
"     </b>",
"     Oral solution: 15 mL as a single dose; maximum single daily dose: 45 mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Bowel cleansing prior to colonoscopy:",
"     </b>",
"     Oral tablets:",
"     <b>",
"      Note:",
"     </b>",
"     Do not use additional agents, especially other sodium phosphate products.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Visicol&reg;:",
"     </i>",
"     A total of 40 tablets and 3.6 quarts of clear liquids (8 ounces of clear liquids with each dose) divided as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Evening before colonoscopy: 3 tablets every 15 minutes for 6 doses, then 2 additional tablets in 15 minutes (total of 20 tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     3-5 hours prior to colonoscopy: 3 tablets every 15 minutes for 6 doses, then 2 additional tablets in 15 minutes (total of 20 tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      OsmoPrep&reg;:",
"     </i>",
"     A total of 32 tablets and 2 quarts of clear liquids (8 ounces of clear liquids with each dose) divided as follows:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Evening before colonoscopy: 4 tablets every 15 minutes for 5 doses (total of 20 tablets)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     3-5 hours prior to colonoscopy: 4 tablets every 15 minutes for 3 doses (total of 12 tablets)",
"    </p>",
"   </div>",
"   <div class=\"block dop drugH1Div\" id=\"F221985\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Pediatric",
"    </span>",
"    <p>",
"     (For additional information",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/47/36599?source=see_link\">",
"      see \"Sodium phosphate: Pediatric drug information\"",
"     </a>",
"     )",
"    </p>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Caution: With orders for I.V. phosphate, there is considerable confusion associated with the use of millimoles (mmol) versus milliequivalents (mEq) to express the phosphate requirement.",
"     </b>",
"     The most reliable method of ordering I.V. phosphate is by millimoles, then specifying the potassium or sodium salt. Intravenous doses listed as mmol of phosphate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;\">",
"     <b>",
"      Acute treatment of hypophosphatemia:",
"     </b>",
"     I.V.: It is difficult to provide concrete guidelines for the treatment of severe hypophosphatemia because the extent of total body deficits and response to therapy are difficult to predict. Aggressive doses of phosphate may result in a transient serum elevation followed by redistribution into intracellular compartments or bone tissue. It is recommended that repletion of severe hypophosphatemia be done I.V. because large doses of oral phosphate may cause diarrhea and intestinal absorption may be unreliable. Intermittent I.V. infusion should be reserved for severe depletion situations; requires continuous cardiac monitoring. Guidelines differ based on degree of illness, need/use of TPN, and severity of hypophosphatemia. If hypokalemia exists (some clinicians recommend threshold of &lt;4 mmol/L), consider phosphate replacement strategy with potassium (eg, potassium phosphates). Obese patients and/or severe renal impairment were excluded from phosphate supplement trials.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     There are no prospective studies of parenteral phosphate replacement in children. The following weight-based guidelines for adult dosing may be cautiously employed in pediatric patients. Guidelines differ based on degree of illness, use of TPN, and severity of hypophosphatemia.",
"     <b>",
"      Note:",
"     </b>",
"     1 mmol phosphate = 31 mg phosphorus; 1 mg phosphorus = 0.032 mmol phosphate.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     <i>",
"      General replacement guidelines (Lentz, 1978):",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Low dose, serum phosphorus losses are recent and uncomplicated: 0.08 mmol/kg over 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intermediate dose, serum phosphorus level 0.5-1 mg/dL (0.16-0.32 mmol/L): 0.16-0.24 mmol/kg over 6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     <b>",
"      Note:",
"     </b>",
"     The initial dose may be increased by 25% to 50% if the patient is symptomatic secondary to hypophosphatemia and lowered by 25% to 50% if the patient is hypercalcemic.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     <i>",
"      Critically-ill adult patients receiving concurrent enteral/parenteral nutrition (Brown, 2006; Clark 1995):",
"     </i>",
"     <b>",
"      Note:",
"     </b>",
"     Round doses to the nearest 7.5 mmol for ease of preparation. If administering with phosphate-containing parenteral nutrition, do not exceed 15 mmol/L within parenteral nutrition. May use adjusted body weight for patients weighing &gt;130% of ideal body weight (and BMI &lt;40 kg/m",
"     <sup>",
"      2",
"     </sup>",
"     ) by using [IBW + 0.25 (ABW-IBW)]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Low dose, serum phosphorus level 2.3-3 mg/dL (0.74-0.96 mmol/L): 0.16-0.32 mmol/kg over 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     Intermediate dose, serum phosphorus level 1.6-2.2 mg/dL (0.51-0.71 mmol/L): 0.32-0.64 mmol/kg over 4-6 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:6em;text-align:justify;\">",
"     High dose, serum phosphorus &lt;1.5 mg/dL (&lt;0.5 mmol/L): 0.64-1 mmol/kg over 8-12 hours",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Parenteral nutrition:",
"     </b>",
"     I.V.:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Infants and Children: 0.5-2 mmol/kg/24 hours (Mirtallo, 2004 [ASPEN guidelines])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;margin-top:0em;text-align:justify;\">",
"     Children &gt;50 kg and Adolescents: 10-40 mmol/24 hours (Mirtallo, 2004 [ASPEN guidelines])",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Laxative (Fleet&reg;):",
"     </b>",
"     Rectal:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 2-4 years: One-half contents of one 2.25 oz pediatric enema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 5-11 years: Contents of one 2.25 oz pediatric enema",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;margin-top:2em;text-align:justify;\">",
"     <b>",
"      Laxative:",
"     </b>",
"     Oral solution:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 5-9 years: 7.5 mL as a single dose; maximum single daily dose: 7.5 mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children 10-11 years: 15 mL as a single dose; maximum single daily dose: 15 mL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Children &ge;12 years: Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block doe drugH1Div\" id=\"F221981\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Geriatric",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution due to increased risk of renal impairment in the elderly. Refer to adult dosing.",
"    </p>",
"   </div>",
"   <div class=\"block dor drugH1Div\" id=\"F221982\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Renal Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use with caution; ionized inorganic phosphate is excreted by the kidneys. Oral solution is contraindicated in patients with kidney disease.",
"    </p>",
"   </div>",
"   <div class=\"block doh drugH1Div\" id=\"F13298046\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosing: Hepatic Impairment",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Not expected to be metabolized in the liver.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F221959\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Excipient information presented when available (limited, particularly for generics); consult specific product labeling.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, solution [concentrate; preservative free]: Phosphorus 3 mmol and sodium 4 mEq per 1 mL (5 mL, 15 mL, 50 mL) [equivalent to phosphorus 93 mg and sodium 92 mg per 1 mL; source of electrolytes: monobasic and dibasic sodium phosphate]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, oral: Monobasic sodium phosphate monohydrate 2.4 g and dibasic sodium phosphate heptahydrate 0.9 g per 5 mL (45 mL) [sugar free; contains sodium 556 mg/5 mL, sodium benzoate; ginger-lemon flavor]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Solution, rectal [enema]: Monobasic sodium phosphate monohydrate 19 g and dibasic sodium phosphate heptahydrate 7 g per 118 mL delivered dose (133 mL)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Enema: Monobasic sodium phosphate monohydrate 19 g and dibasic sodium phosphate heptahydrate 7 g per 118 mL delivered dose (133 mL) [contains sodium 4.4 g/118 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Enema Extra&reg;: Monobasic sodium phosphate monohydrate 19 g and dibasic sodium phosphate heptahydrate 7 g per 197 mL delivered dose (230 mL) [contains sodium 4.4 g/197 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     Fleet&reg; Pedia-Lax&trade; Enema: Monobasic sodium phosphate monohydrate 9.5 g and dibasic sodium phosphate heptahydrate 3.5 g per 59 mL delivered dose (66 mL) [contains sodium 2.2 g/59 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     LaCrosse Complete: Monobasic sodium phosphate monohydrate 19 g and dibasic sodium phosphate heptahydrate 7 g per 118 mL delivered dose (133 mL) [contains sodium 4.4 g/118 mL]",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Tablet, oral [scored]:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     OsmoPrep&reg;, Visicol&reg;: Monobasic sodium phosphate monohydrate 1.102 g and dibasic sodium phosphate anhydrous 0.398 g [sodium phosphate 1.5 g per tablet; gluten free]",
"    </p>",
"   </div>",
"   <div class=\"block geq drugH1Div\" id=\"F221943\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Generic Equivalent Available: U.S.",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Yes: Enema, injection, oral solution",
"    </p>",
"   </div>",
"   <div class=\"block meg drugH1Div\" id=\"F7874991\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Guide",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     An FDA-approved patient medication guide, which is available with the product information and as follows, must be dispensed with this medication:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     OsmoPrep&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM135936.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM135936.pdf",
"     </a>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Visicol&reg;:",
"     <a href=\"file://www.fda.gov/downloads/Drugs/DrugSafety/UCM134684.pdf\" target=\"_blank\">",
"      file://www.fda.gov/downloads/Drugs/DrugSafety/UCM134684.pdf",
"     </a>",
"    </p>",
"   </div>",
"   <div class=\"block adm drugH1Div\" id=\"F221962\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Administration",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intermittent I.V. infusion; do",
"     <b>",
"      not",
"     </b>",
"     administer I.V. push. Must be diluted prior to parenteral administration. In general, the dose, concentration of infusion, and rate of administration may be dependent on patient condition and specific institution policy. Intermittent infusion doses are typically prepared in 100-250 mL of NS or D",
"     <sub>",
"      5",
"     </sub>",
"     W (usual concentration range: 0.15-0.6 mmol/mL). For adult patients with severe symptomatic hypophosphatemia (ie, &lt;1.5 mg/dL), may administer at rates up to 15 mmol/hour (Charron, 2003; Rosen, 1995). In patients with renal dysfunction and/or less severe hypophosphatemia, slower administration rates (eg, over 4-6 hours) or oral repletion is recommended.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Bowel cleansing: Have patient drink ~8 ounces of clear liquids with each dose of sodium phosphate (total recommended volume is product specific); have patient rehydrate before and after colonoscopy. Clear liquids may include water, flavored water, pulp-free lemonade, ginger ale, or apple juice; purple or red colored liquids should be avoided.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Constipation: Take on an empty stomach; dilute dose with 8 ounces cool water, then follow dose with 8 ounces water;",
"     <b>",
"      do not repeat dose within 24 hours",
"     </b>",
"    </p>",
"   </div>",
"   <div class=\"block scp drugH1Div\" id=\"F221993\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Compatibility",
"    </span>",
"    <p style=\"text-indent:0em;text-align:justify;display:inline\">",
"     <b>",
"      Y-site administration: Compatible:",
"     </b>",
"     Doripenem, micafungin, telavancin.",
"     <b>",
"      Incompatible:",
"     </b>",
"     Amiodarone.",
"     <b>",
"      Variable (consult detailed reference):",
"     </b>",
"     Ciprofloxacin, TPN.",
"    </p>",
"   </div>",
"   <div class=\"block use drugH1Div\" id=\"F221960\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Use",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral solution, rectal: Short-term treatment of constipation",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral tablets (OsmoPrep&reg;, Visicol&reg;): Bowel cleansing prior to colonoscopy",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Source of phosphate in large volume I.V. fluids and parenteral nutrition; treatment and prevention of hypophosphatemia",
"    </p>",
"   </div>",
"   <div class=\"block mst drugH1Div\" id=\"F2931717\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Medication Safety Issues",
"    </span>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Sound-alike/look-alike issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;\">",
"       Visicol&reg; may be confused with Asacol&reg;, VESIcare&reg;",
"      </p>",
"     </div>",
"    </div>",
"    <div class=\"collapsible\">",
"     <span class=\"collapsible-title\">",
"      Administration issues:",
"     </span>",
"     <div class=\"collapsible-wrap\">",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Enemas and oral solution are available in pediatric and adult sizes; prescribe by &ldquo;volume&rdquo; not by &ldquo;bottle.&rdquo;",
"      </p>",
"      <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"       Because inorganic phosphate exists as monobasic and dibasic anions, with the mixture of valences dependent on pH, ordering by mEq amounts is unreliable and may lead to large dosing errors. In addition, I.V. phosphate is available in the sodium and potassium salt; therefore, the content of these cations must be considered when ordering phosphate. The most reliable method of ordering I.V. phosphate is by millimoles, then specifying the potassium or sodium salt.",
"      </p>",
"     </div>",
"    </div>",
"   </div>",
"   <div class=\"block ars drugH1Div\" id=\"F221987\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Adverse Reactions Significant",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Frequency not always defined.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Central nervous system: Dizziness, headache",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Gastrointestinal: Bloating (31% to 47%), nausea (26% to 35%), abdominal pain (23% to 30%), vomiting (4% to 7%), mucosal bleeding, superficial mucosal ulcerations",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Endocrine &amp; metabolic: Hyperphosphatemia (&le;96%), hypocalcemia (on colonoscopy day; 47%), hypophosphatemia (2-3 days postcolonoscopy; 34%), hypokalemia (on colonoscopy day; 28%), hypernatremia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Postmarketing and/or case reports (Limited to important or life-threatening): Acute phosphate nephropathy, anaphylaxis, bronchospasm, calcium nephrolithiasis, cardiac arrhythmia, dehydration, dysphagia, dyspnea, facial edema, increased blood urea nitrogen, increased serum creatinine, ischemic colitis, lip edema, paresthesia, pharyngeal edema, pruritus, rectal bleeding, renal failure, renal insufficiency, renal tubular necrosis, seizure, skin rash, tightness in throat, tongue edema, urticaria",
"    </p>",
"   </div>",
"   <div class=\"block coi drugH1Div\" id=\"F221965\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Contraindications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Hypersensitivity to sodium phosphate salts or any component of the formulation; additional contraindications vary by product:",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Enema: Ascites, clinically significant renal impairment, heart failure, imperforate anus, known or suspected GI obstruction, megacolon (congenital or acquired)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Intravenous preparation: Diseases with hyperphosphatemia, hypocalcemia, or hypernatremia",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral preparation: Acute phosphate nephropathy (biopsy proven), bowel obstruction, bowel perforation, gastric bypass or stapling surgery, toxic colitis, toxic megacolon",
"    </p>",
"   </div>",
"   <div class=\"block war drugH1Div\" id=\"F221947\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Warnings/Precautions",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Concerns related to adverse effects:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Nephropathy:",
"     <b>",
"      [U.S. Boxed Warning]: Acute phosphate nephropathy has been reported (rarely) with use of oral products as a colon cleanser prior to colonoscopy. Some cases have resulted in permanent renal impairment (some requiring dialysis). Risk factors for acute phosphate nephropathy may include increased age (&gt;55 years of age), pre-existing renal dysfunction, bowel obstruction, active colitis, or dehydration, and the use of medicines that affect renal perfusion or function (eg, ACE inhibitors, angiotensin receptor blockers, diuretics, and possibly NSAIDs), although some cases have been reported in patients without apparent risk factors.",
"     </b>",
"     Other preventive measures may include avoid exceeding maximum recommended doses and concurrent use of other laxatives containing sodium phosphate; encourage patients to adequately hydrate before, during, and after use; obtain baseline and postprocedure labs in patients at risk; consider hospitalization and intravenous hydration during bowel cleansing for patients unable to hydrate themselves (eg, frail patients). Use is contraindicated in patients with acute phosphate nephropathy (biopsy proven).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; QT prolongation: Prolongation of the QT interval has been reported (associated with hypokalemia, hypocalcemia).",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Disease-related concerns:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Cardiovascular:  Use caution in patients with heart failure (contraindicated with enema products), unstable angina, history of myocardial infarction arrhythmia, cardiomyopathy; use caution in patients with or at risk for arrhythmias (eg, cardiomyopathy, prolonged QT interval, history of uncontrolled arrhythmias, recent MI) or with concurrent use of other QT-prolonging medications; pre-/postdose ECGs should be considered in high-risk patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Electrolyte disturbances: Use with caution in patients with pre-existing electrolyte imbalances, dehydration, or risk of electrolyte disturbance (hypocalcemia, hyperphosphatemia, hypernatremia). Correct dehydration prior to using for bowel preparations.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Gastrointestinal disorders: Use caution in patients with any of the following: Gastric retention or hypomotility, ileus, severe, chronic constipation, or colitis. Use is contraindicated in patients with bowel obstruction (including pseudo) or perforation, congenital megacolon, gastric bypass or bariatric surgery, toxic colitis, or toxic megacolon.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Inflammatory bowel disease: Use with caution in patients with chronic inflammatory bowel disease or severe active ulcerative colitis; may induce colonic aphthous ulceration and ischemic colitis (some requiring hospitalization). Colitis has been associated with acute phosphate nephropathy.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Renal impairment: Use with caution in patients with renal impairment; patients may be at risk for sodium retention and edema. Close monitoring required to avoid hyperphosphatemia.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Seizure disorder: Use with caution in patients with a history of seizures, those at higher risk of seizures or on medication that lowers seizure threshold.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Special populations:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bulimia nervosa patients: Laxatives and purgatives have the potential for abuse by bulimia nervosa patients.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Debilitated patients: Use with caution in debilitated patients; consider each patient&rsquo;s ability to hydrate properly.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Elderly: Use with caution in the elderly; ensure they are able to hydrate themselves if using for bowel preparation.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Impaired gag reflex: Use with caution in patients with impaired gag reflex and those prone to regurgitation or aspiration.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Dosage form specific issues:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Enemas/oral solutions: Available in pediatric and adult sizes; prescribe by &ldquo;volume&rdquo; not  by &ldquo;bottle.&rdquo;",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Solutions for injection: May contain aluminum; toxic levels may occur following prolonged administration in premature neonates or patients with renal impairment.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Visicol&reg;: Use caution with history of swallowing difficulties or esophageal narrowing.  Tablet particles may be seen in the stool.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      <i>",
"       Other warnings/precautions:",
"      </i>",
"     </b>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     &bull; Bowel evacuation: Appropriate use: If using as a bowel evacuant, correct electrolyte abnormalities before administration. Ensure adequate clear liquid intake prior to and during bowel evacuation regimens; inadequate fluid intake may lead to excessive fluid loss and hypovolemia. Other oral medications may not be well absorbed when given during bowel evacuation because of rapid intestinal peristalsis.",
"    </p>",
"   </div>",
"   <div class=\"block cyt drugH1Div\" id=\"F13300067\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Metabolism/Transport Effects",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     None known.",
"    </p>",
"   </div>",
"   <div class=\"block dri drugH1Div\" id=\"F221952\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Drug Interactions",
"    </span>",
"    <br/>",
"    <br/>",
"    <div class=\"lexi\" id=\"lexiInteractAddInfo\">",
"     (For additional information:",
"     <a class=\"dip\" href=\"./drug-interaction\" target=\"_blank\">",
"      Launch Lexi-Interact&trade; Drug Interactions Program",
"     </a>",
"     )",
"    </div>",
"    <div class=\"lexi\" id=\"lexiInteractImgB\">",
"     <img border=\"0\" height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"    </div>",
"    <div class=\"clear\">",
"    </div>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     ACE Inhibitors: May enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced. Management: Consider avoiding this combination by temporarily suspending treatment with ACEIs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Angiotensin II Receptor Blockers: May enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced. Management: Consider avoiding this combination by temporarily suspending treatment with ARBs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Antacids: May decrease the absorption of Phosphate Supplements.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Bisphosphonate Derivatives: May enhance the hypocalcemic effect of Phosphate Supplements.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Calcium Salts: May decrease the absorption of Phosphate Supplements.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Diuretics: May enhance the nephrotoxic effect of Sodium Phosphates. Specifically, the risk of acute phosphate nephropathy may be enhanced. Management: Consider avoiding this combination by temporarily suspending treatment with diuretics, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, hydrate adequately and monitor fluid and renal status.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Iron Salts: May decrease the absorption of Phosphate Supplements. Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, oral iron salt administration.",
"     <b>",
"      Exceptions:",
"     </b>",
"     Ferumoxytol; Iron Dextran Complex; Iron Sucrose.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Magnesium Salts: May decrease the serum concentration of Phosphate Supplements. Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, oral magnesium salt administration.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Multivitamins/Minerals (with ADEK, Folate, Iron): May decrease the serum concentration of Phosphate Supplements. Management: Administer oral phosphate supplements at least 1 hour before, or 2 hours after, administration of an iron-containing multivitamin.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Nonsteroidal Anti-Inflammatory Agents: Sodium Phosphates may enhance the nephrotoxic effect of Nonsteroidal Anti-Inflammatory Agents. Specifically, the risk of acute phosphate nephropathy may be enhanced.  Management: Consider avoiding this combination by temporarily suspending treatment with NSAIDs, or seeking alternatives to oral sodium phosphate bowel preparation. If the combination cannot be avoided, maintain adequate hydration and monitor renal function closely.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Sucralfate: May decrease the absorption of Phosphate Supplements.",
"     <i>",
"      Risk D: Consider therapy modification",
"     </i>",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Tricyclic Antidepressants: May enhance the adverse/toxic effect of Sodium Phosphates. Specifically, the risk of seizure and/or loss of consciousness may be increased in patients with significant sodium phosphate induced fluid/electrolyte abnormalities.",
"     <i>",
"      Risk C: Monitor therapy",
"     </i>",
"    </p>",
"   </div>",
"   <div class=\"block prf drugH1Div\" id=\"F221954\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Risk Factor",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     C (",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?16/42/17068\">",
"      show table",
"     </a>",
"     )",
"    </p>",
"   </div>",
"   <div class=\"block pri drugH1Div\" id=\"F221968\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pregnancy Implications",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Reproduction studies have not been conducted with these products. Use with caution in pregnant women.",
"    </p>",
"   </div>",
"   <div class=\"block lac drugH1Div\" id=\"F221983\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Lactation",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Use caution in nursing women.",
"    </p>",
"   </div>",
"   <div class=\"block brc drugH1Div\" id=\"F7828343\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Breast-Feeding Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Phosphorus, sodium, and potassium are normal constituents of human milk.",
"    </p>",
"   </div>",
"   <div class=\"block dic drugH1Div\" id=\"F221969\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dietary Considerations",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Bowel cleansing: Should be taken on an empty stomach with clear liquids; a clear liquid diet should be used for 12 hours prior to and during tablet administration. Clear liquids may include water, flavored water, pulp-free lemonade, ginger ale, or apple juice; purple or red colored liquids should be avoided. Some products may contain phenylalanine and/or sodium.",
"    </p>",
"   </div>",
"   <div class=\"block fee drugH1Div\" id=\"F221967\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pricing: U.S. (Medi-Span&reg;)",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Enema",
"     </b>",
"     (Enema Rectal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7-19 g/118 mL (133 mL): $1.20",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Enema",
"     </b>",
"     (Fleet Enema Rectal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     7-19 g/118 mL (133 mL): $1.12",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Enema",
"     </b>",
"     (Fleet Pediatric Rectal)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3.5-9.5 g/59 mL (66 mL): $1.44",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Solution",
"     </b>",
"     (Sodium Phosphate Intravenous)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     3 mmol/mL (15 mL): $2.17",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (OsmoPrep Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.102-0.398 g (100): $409.90",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     <b>",
"      Tablets",
"     </b>",
"     (Visicol Oral)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;text-align:justify;\">",
"     1.102-0.398 g (40): $181.96",
"    </p>",
"   </div>",
"   <div class=\"block mop drugH1Div\" id=\"F221957\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Monitoring Parameters",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     I.V.: Serum calcium, sodium and phosphorus levels; renal function; after I.V. phosphate repletion, repeat serum phosphorus level should be checked 2-4 hours later",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Oral: Bowel cleansing: Baseline and postprocedure labs (electrolytes, calcium, phosphorus, BUN, creatinine) in patients at risk for acute renal nephropathy, seizure, or who have a history of electrolyte abnormality; ECG in patients with risks for prolonged QT or arrhythmias. Ensure euvolemia before initiating bowel preparation.",
"    </p>",
"   </div>",
"   <div class=\"block rer drugH1Div\" id=\"F13203132\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reference Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     <b>",
"      Note:",
"     </b>",
"     Reference ranges may vary depending on the laboratory",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum calcium: 8.4-10.2 mg/dL",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Serum phosphorus: Both low and high ends of the normal range are higher in children than in adults.",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Infants: 4.5-7.5 mg/dL (1.45-2.42 mmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Children: ~4.0-6.0 mg/dL (1.29-1.94 mmol/L)",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:4em;\">",
"     Adults: 2.5-4.5 mg/dL (0.81-1.45 mmol/L)",
"    </p>",
"   </div>",
"   <div class=\"block pha drugH1Div\" id=\"F221946\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Mechanism of Action",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     As a laxative, exerts osmotic effect in the small intestine by drawing water into the lumen of the gut, producing distention and promoting peristalsis and evacuation of the bowel; phosphorous participates in bone deposition, calcium metabolism, utilization of B complex vitamins, and as a buffer in acid-base equilibrium",
"    </p>",
"   </div>",
"   <div class=\"block phk drugH1Div\" id=\"F221964\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacodynamics/Kinetics",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Onset of action: Cathartic: 3-6 hours; Rectal: 2-5 minutes",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Absorption: Oral: ~1% to 20%",
"    </p>",
"    <p style=\"text-indent:-2em;margin-left:2em;text-align:justify;\">",
"     Excretion: Urine",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <div class=\"reference\">",
"      Brown KA, Dickerson RN, Morgan LM, et al, &ldquo;A New Graduated Dosing Regimen for Phosphorus Replacement in Patients Receiving Nutrition Support,&rdquo;",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2006, 30(3):209-14.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/16639067/pubmed\" id=\"16639067\" target=\"_blank\">",
"        16639067",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Charron T, Bernard F, Skrobik Y, et al, &ldquo;Intravenous Phosphate in the Intensive Care Unit: More Aggressive Repletion Regimens for Moderate and Severe Hypophosphatemia,&rdquo;",
"      <i>",
"       Intensive Care Med",
"      </i>",
"      , 2003, 29(8):1273-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/12845429/pubmed\" id=\"12845429\" target=\"_blank\">",
"        12845429",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Clark CL, Sacks GS, Dickerson RN, et al, &ldquo;Treatment of Hypophosphatemia in Patients Receiving Specialized Nutrition Support Using a Graduated Dosing Scheme: Results from a Prospective Clinical Trial,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1995, 23(9):1504-11.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/7664552/pubmed\" id=\"7664552\" target=\"_blank\">",
"        7664552",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dickerson R, &ldquo;Treating Hypophosphatemia,&rdquo;",
"      <i>",
"       Hosp Pharm",
"      </i>",
"      , 1985, 20:920-24.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Dagago, JS, &ldquo;Chapter 24: Mineral and Metabolic Bone Disease,&rdquo;",
"      <i>",
"       Washington Manual of Therapeutics",
"      </i>",
"      , 29th ed, Carey CF  and Schaiff R, eds, Philadelphia, PA: Lippincott-Raven, 1998.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Gonlusen G, Akgun H, Ertan A, et al, &ldquo;Renal Failure and Nephrocalcinosis Associated With Oral Sodium Phosphate Bowel Cleansing: Clinical Patterns and Renal Biopsy Findings,&rdquo;",
"      <i>",
"       Arch Pathol Lab Med",
"      </i>",
"      , 2006, 130(1):101-6.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/16390223/pubmed\" id=\"16390223\" target=\"_blank\">",
"        16390223",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Hicks W and Hardy G, &ldquo;Phosphate Supplementation for Hypophosphatemia and Parenteral Nutrition,&rdquo;",
"      <i>",
"       Curr Opin Clin Nutr Metab Care",
"      </i>",
"      , 2001, 4(3):227-33.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/11517357/pubmed\" id=\"11517357\" target=\"_blank\">",
"        11517357",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      IOM (Institute of Medicine),",
"      <i>",
"       Dietary Reference Intakes for Calcium, Phosphorus, Magnesium, Vitamin D, and Fluoride",
"      </i>",
"      , National Academy of Sciences, Washington, DC, 1997.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Khurana A, McLean L, Atkinson S, et al, \"The Effect of Oral Sodium Phosphate Drug Products on Renal Function in Adults Undergoing Bowel Endoscopy,\"",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2008, 168(6):593-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lentz RD, Brown BM, and Kjellstrand CM, &ldquo;Treatment of Severe Hypophosphatemia,&rdquo;",
"      <i>",
"       Ann Intern Med",
"      </i>",
"      , 1978, 89(6):941-4.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/102230/pubmed\" id=\"102230\" target=\"_blank\">",
"        102230",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Lloyd CW and Johnson CE, &ldquo;Management of Hypophosphatemia,&rdquo;",
"      <i>",
"       Clin Pharm",
"      </i>",
"      , 1988, 7(2):123-8.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/3280219/pubmed\" id=\"3280219\" target=\"_blank\">",
"        3280219",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Markowitz GS, Stokes MB, Radhakrishnan J, et al, &ldquo;Acute Phosphate Nephropathy Following Oral Sodium Phosphate Bowel Purgative: An Under Recognized Cause of Chronic Renal Failure,&rdquo;",
"      <i>",
"       J Am Soc Nephrol",
"      </i>",
"      , 2005, 16(11):3389-96.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/16192415/pubmed\" id=\"16192415\" target=\"_blank\">",
"        16192415",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Mirtallo J, Canada T, Johnson D, et al, &ldquo;Safe Practices for Parenteral Nutrition,&rdquo;",
"      <i>",
"       JPEN J Parenter Enteral Nutr",
"      </i>",
"      , 2004, 28(6):S39-70.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/15568296/pubmed\" id=\"15568296\" target=\"_blank\">",
"        15568296",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      <i>",
"       Physician's Desk Reference",
"      </i>",
"      , 54th ed, Montvale, NJ: Medical Economics Co, 2000.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Rosen GH, Boullata JI, O'Rangers EA, et al, &ldquo;Intravenous Phosphate Repletion Regimen for Critically Ill Patients With Moderate Hypophosphatemia,&rdquo;",
"      <i>",
"       Crit Care Med",
"      </i>",
"      , 1995, 23(7):1204-10.",
"      <span class=\"pubmed-id\">",
"       [PubMed",
"       <a href=\"UTD.htm?5/22/5480/abstract-text/7600828/pubmed\" id=\"7600828\" target=\"_blank\">",
"        7600828",
"       </a>",
"       ]",
"      </span>",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      Roy HK and Bianchi LK, \"Purging the Colon While Preserving the Kidneys,\"",
"      <i>",
"       Arch Intern Med",
"      </i>",
"      , 2008, 168(6): 565-7.",
"     </div>",
"    </li>",
"    <li>",
"     <div class=\"reference\">",
"      &ldquo;Safe Practices for Parenteral Nutrition Formulations,&rdquo; National Advisory Group on Standards and Practice Guidelines for Parenteral Nutrition,",
"      <i>",
"       J Parenter Enteral Nutr",
"      </i>",
"      , 1998, 22(2):49-66.",
"     </div>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10269 Version 36.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-211.167.112.14-E9FFDB1ABC-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5480=[""].join("\n");
var outline_f5_22_5480=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7688983\">",
"      ALERT: U.S. Boxed Warning",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221976\">",
"      Brand Names: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221977\">",
"      Brand Names: Canada",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221989\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221980\">",
"      Dosing: Adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221985\">",
"      Dosing: Pediatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221981\">",
"      Dosing: Geriatric",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221982\">",
"      Dosing: Renal Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13298046\">",
"      Dosing: Hepatic Impairment",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221959\">",
"      Dosage Forms: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221943\">",
"      Generic Equivalent Available: U.S.",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7874991\">",
"      Medication Guide",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221962\">",
"      Administration",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221993\">",
"      Compatibility",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221960\">",
"      Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F2931717\">",
"      Medication Safety Issues",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221987\">",
"      Adverse Reactions Significant",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221965\">",
"      Contraindications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221947\">",
"      Warnings/Precautions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13300067\">",
"      Metabolism/Transport Effects",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221952\">",
"      Drug Interactions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221954\">",
"      Pregnancy Risk Factor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221968\">",
"      Pregnancy Implications",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221983\">",
"      Lactation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F7828343\">",
"      Breast-Feeding Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221969\">",
"      Dietary Considerations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221967\">",
"      Pricing: U.S. (Medi-Span&reg;)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221957\">",
"      Monitoring Parameters",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F13203132\">",
"      Reference Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221946\">",
"      Mechanism of Action",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F221964\">",
"      Pharmacodynamics/Kinetics",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10269\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_GEN/10269|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_patient\" href=\"UTD.htm?19/15/19702?source=related_link\">",
"      Sodium phosphate: Patient drug information",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"drug drug_pediatric\" href=\"UTD.htm?35/47/36599?source=related_link\">",
"      Sodium phosphate: Pediatric drug information",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_22_5481="Clinical features and diagnosis of Guillain-Barré syndrome in adults";
var content_f5_22_5481=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/wk_utd-rgb.myextg\" width=\"220px\">",
"   </img>",
"  </div>",
"  <div id=\"printHeaderText\">",
"   Official reprint from  UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"   <a href=\"file://www.uptodate.com\">",
"    www.uptodate.com",
"   </a>",
"   <br>",
"    &copy;2013 UpToDate",
"    <sup>",
"     &reg;",
"    </sup>",
"   </br>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"4\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Clinical features and diagnosis of Guillain-Barr&eacute; syndrome in adults",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/22/5481/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5481/contributors\">",
"     Francine J Vriesendorp, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/22/5481/contributors\">",
"     Section Editors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5481/contributors\">",
"     Jeremy M Shefner, MD, PhD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5481/contributors\">",
"     Ira N Targoff, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/22/5481/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5481/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/22/5481/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Feb 4, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The acute immune-mediated polyneuropathies are classified under the eponym Guillain-Barr&eacute; syndrome (GBS), after the authors of early descriptions of the disease. Guillain-Barr&eacute; syndrome is a heterogeneous condition with several variant forms. Most often, GBS presents as an acute monophasic paralyzing illness provoked by a preceding infection.",
"   </p>",
"   <p>",
"    The clinical features and diagnosis of GBS in adults will be reviewed here. Other aspects of GBS are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/265?source=see_link\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27705?source=see_link\">",
"     \"Overview of Guillain-Barr&eacute; syndrome in children\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41781?source=see_link\">",
"     \"Treatment of Guillain-Barr&eacute; syndrome in children\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H284586891\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;GBS occurs world-wide with an overall incidence of 1 to 2 per 100,000 per year [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/1,2\">",
"     1,2",
"    </a>",
"    ]. While all age groups are affected, the incidence increases by approximately 20 percent with every 10-year increase in age beyond the first decade of life. In addition, the incidence is greater in males than in females.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;The cardinal clinical features of Guillain-Barr&eacute; syndrome (GBS) are progressive, fairly symmetric muscle weakness accompanied by absent or depressed deep tendon reflexes. Patients usually present a few days to a week after onset of symptoms. The weakness can vary from mild difficulty with walking to nearly complete paralysis of all extremity, facial, respiratory, and bulbar muscles.",
"   </p>",
"   <p>",
"    Studies from the United States and Europe, reflecting primarily patients with acute inflammatory demyelinating polyneuropathy (AIDP), show that GBS is associated with the following clinical features [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/3\">",
"     3",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Although the weakness usually starts in the legs, it begins in the arms or facial muscles in about 10 percent of patients.",
"     </li>",
"     <li>",
"      Severe respiratory muscle weakness necessitating ventilatory support develops in 10 to 30 percent [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/4\">",
"       4",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Facial weakness occurs in more than 50 percent and oropharyngeal weakness eventually occurs in 50 percent.",
"     </li>",
"     <li>",
"      Oculomotor weakness occurs in about 15 percent of patients.",
"     </li>",
"     <li>",
"      Paresthesias in the hands and feet accompany the weakness in more than 80 percent of patients, but sensory abnormalities on examination are frequently mild.",
"     </li>",
"     <li>",
"      Pain, typically located in the back and extremities, can be a presenting feature and is reported during the acute phase by 66 percent of patients with all forms of GBS [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/5,6\">",
"       5,6",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Dysautonomia occurs in 70 percent of patients and manifests as symptoms that include tachycardia (the most common), urinary retention, hypertension alternating with hypotension, orthostatic hypotension, bradycardia, other arrhythmias, ileus, and loss of sweating. Severe autonomic dysfunction is important to recognize since this is occasionally associated with sudden death [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/7\">",
"       7",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Unusual features of GBS include papilledema, facial myokymia, hearing loss, meningeal signs, vocal cord paralysis, and mental status changes [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/8\">",
"     8",
"    </a>",
"    ]. The syndrome of inappropriate antidiuretic hormone secretion (SIADH) has also been reported in association with GBS [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/9-12\">",
"     9-12",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    GBS usually progresses over a period of about two weeks. By four weeks after the initial symptoms, 90 percent of GBS patients have reached the nadir of the disease. Disease progression for more than eight weeks is consistent with the diagnosis of chronic inflammatory demyelinating polyradiculoneuropathy (CIDP). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/265?source=see_link\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Laboratory features",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical finding with lumbar puncture in patients with GBS is an elevated cerebrospinal fluid (CSF) protein with a normal white blood cell count. This finding is called albuminocytologic dissociation, and is present in up to 66 percent of patients with GBS at one week after onset of symptoms. (See",
"    <a class=\"local\" href=\"#H11\">",
"     'Cerebrospinal fluid analysis'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Clinical neurophysiology studies (ie, electromyography and nerve conduction studies) show evidence of an acute polyneuropathy with predominantly demyelinating features in acute inflammatory demyelinating polyradiculoneuropathy (AIDP), while the features are predominantly axonal in acute motor axonal neuropathy (AMAN) and acute sensorimotor axonal neuropathy (AMSAN).",
"   </p>",
"   <p>",
"    Glycolipid antibodies may be associated with different forms or aspects of GBS. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40038?source=see_link&amp;anchor=H3#H3\">",
"     \"Pathogenesis of Guillain-Barr&eacute; syndrome in adults\", section on 'Molecular mimicry'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Antibodies against GQ1b (a ganglioside component of nerve) are found in 85 to 90 percent of patients with the Miller Fisher syndrome. (See",
"      <a class=\"local\" href=\"#H389462\">",
"       'Miller Fisher syndrome'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Antibodies to GM1, GD1a, GalNac-GD1a, and GD1b are mostly associated with axonal variants of GBS. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Acute motor axonal neuropathy'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H8\">",
"       'Acute motor and sensory axonal neuropathy'",
"      </a>",
"      below.)",
"     </li>",
"     <li>",
"      Antibodies to GT1a are associated with swallowing dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/13\">",
"       13",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Antibodies to GD1b are associated with pure sensory GBS [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/14\">",
"       14",
"      </a>",
"      ]. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Other variants'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Laboratory testing for patients with GBS is discussed below. (See",
"    <a class=\"local\" href=\"#H10\">",
"     'Diagnostic evaluation'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     GBS VARIANTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Historically, the Guillain-Barr&eacute; syndrome (GBS) was considered a single disorder. It now is recognized as a heterogeneous syndrome with several variant forms. Each form of GBS has distinguishing clinical, pathophysiologic, and pathologic features.",
"   </p>",
"   <p>",
"    Acute inflammatory demyelinating polyradiculoneuropathy (AIDP) is the most common form in the United States and Europe, representing approximately 85 to 90 percent of cases. The clinical variant Miller Fisher syndrome (MFS), characterized by ophthalmoplegia, ataxia, and areflexia, occurs in 5 percent of cases in the United States and 25 percent of cases in Japan [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Acute motor axonal neuropathy (AMAN) and acute sensorimotor axonal neuropathy (AMSAN) are primary axonal forms of GBS. These forms are frequently observed in China, Japan, and Mexico, but they also comprise an estimated 5 to 10 percent of GBS cases in the United States [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/16\">",
"     16",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Other, less frequent, clinical variants are recognized and listed below. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'Other variants'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Acute inflammatory demyelinating polyneuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;As noted above, AIDP is the most common form in the United States and Europe, representing approximately 85 to 90 percent of cases. The typical clinical features are a progressive, fairly symmetric muscle weakness accompanied by absent or depressed deep tendon reflexes. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Peripheral nerve myelin is the target of immune attack in AIDP. The immunologic basis of peripheral nerve demyelination in AIDP is discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40038?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of Guillain-Barr&eacute; syndrome in adults\", section on 'Mechanisms'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Inflammatory demyelination is thought to start at the level of the nerve roots, leading to electrophysiologic conduction slowing and conduction blocks with resultant muscle weakness. Multifocal, patchy, widespread peripheral nerve demyelination follows, causing increasing paralysis. Peripheral nerve remyelination occurs relatively rapidly over several weeks to months. However, in a small percentage of patients, there is superimposed significant axonal degeneration with markedly delayed and incomplete recovery.",
"   </p>",
"   <p>",
"    The earliest abnormalities seen on clinical neurophysiology studies in patients with AIDP are prolonged or absent F waves and absent H reflexes, reflecting demyelination at the level of the nerve roots [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/17,18\">",
"     17,18",
"    </a>",
"    ]. Increased distal latencies and conduction blocks with temporal dispersion of motor responses follow [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/19,20\">",
"     19,20",
"    </a>",
"    ]. Significant slowing of nerve conduction velocities is usually not seen until the third or fourth week [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/20\">",
"     20",
"    </a>",
"    ]. Sensory nerve conduction studies (NCS) reveal absent responses or slowed conduction velocities. Typically, the sural sensory response is normal, while median and ulnar sensory responses are affected (sural sparing) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/18,21\">",
"     18,21",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Needle examination (electromyography [EMG]) of weak muscles shows reduced recruitment. Ancillary studies, such as facial NCS and blink reflexes, are occasionally helpful.",
"   </p>",
"   <p>",
"    An average distal motor response amplitude reduction to less than 20 percent of normal, measured within 30 days after onset of symptoms, has been shown to predict poorer recovery [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A small percentage of AIDP patients develop severe secondary axonal degeneration, and clinical neurophysiology studies in these patients at three to four weeks after GBS onset show loss of motor and sensory responses on NCS with extensive denervation on needle examination.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Acute motor axonal neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;An acute axonal form of GBS, now known as acute motor axonal neuropathy (AMAN), was first recognized in 1986 [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/23\">",
"     23",
"    </a>",
"    ]. Most cases are preceded by Campylobacter jejuni infection. AMAN occurs frequently in Japan and China, particularly in young people. AMAN has a seasonal incidence, being more frequent in the summer.",
"   </p>",
"   <p>",
"    Deep tendon reflexes are occasionally preserved in patients with AMAN [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/24\">",
"     24",
"    </a>",
"    ]. Sensory nerves are not affected. The presenting clinical features and recovery of AMAN are otherwise similar to those of AIDP.",
"   </p>",
"   <p>",
"    This disorder is distinguished from AIDP by its selective involvement of motor nerves and by an electrophysiologic pattern of axonal involvement. In AMAN, distal motor amplitudes are low initially but may increase rapidly with recovery of function; these findings may reflect reversible conduction failure, possibly at the motor nerve terminal or node of Ranvier [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/25,26\">",
"     25,26",
"    </a>",
"    ]. There is no sensory nerve involvement and no peripheral nerve demyelination. F waves may be absent but are not significantly prolonged. There is no significant slowing of conduction velocities or increase in distal latencies. There is no temporal dispersion.",
"   </p>",
"   <p>",
"    The development of AMAN and AMSAN has been strongly associated with antibodies to the gangliosides GM1, GD1a, GalNac-GD1a, and GD1b that are present in peripheral nerve axons. These anti-ganglioside antibodies can be induced by Campylobacter jejuni infection. The pathophysiology is that of antibody and complement mediated axonal nerve damage without significant axonal degeneration. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40038?source=see_link&amp;anchor=H2#H2\">",
"     \"Pathogenesis of Guillain-Barr&eacute; syndrome in adults\", section on 'Mechanisms'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Acute motor and sensory axonal neuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;AMSAN is a more severe form of AMAN, in which both sensory and motor fibers are affected with marked axonal degeneration, causing delayed and incomplete recovery [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/27\">",
"     27",
"    </a>",
"    ]. Clinically, AMSAN resembles the AMAN variant but has more sensory symptoms. The pathology is predominantly axonal lesions of both motor and sensory nerve fibers.",
"   </p>",
"   <p>",
"    In AMSAN, motor and sensory responses are frequently severely reduced or absent on clinical neurophysiology studies. Axonal degeneration in these patients is demonstrated by extensive denervation on follow-up EMG studies.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H389462\">",
"    <span class=\"h2\">",
"     Miller Fisher syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;The typical presentation of MFS is that of ophthalmoplegia with ataxia and areflexia [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/15,28\">",
"     15,28",
"    </a>",
"    ]. About one-quarter of patients who present with MFS will develop some extremity weakness, clearly linking this disorder to GBS. Incomplete forms include acute ophthalmoplegia without ataxia, and acute ataxic neuropathy without ophthalmoplegia [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/1,29\">",
"     1,29",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Antibodies against GQ1b (a ganglioside component of nerve) are present in 85 to 90 percent of patients with MFS [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/30,31\">",
"     30,31",
"    </a>",
"    ]. The GQ1b antibody is strongly associated with involvement of oculomotor nerves and is also found in most patients with prominent oculomotor weakness and GBS.",
"   </p>",
"   <p>",
"    Clinical neurophysiology studies in patients with MFS reveal reduced or absent sensory responses without slowing of sensory conduction velocities [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/32\">",
"     32",
"    </a>",
"    ]. When there is associated weakness, the motor nerve conduction abnormalities of AIDP may be present.",
"   </p>",
"   <p>",
"    Only a few pathological studies of MFS are available. Two case reports of MFS showed extra-axial oculomotor nerve demyelination [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/33\">",
"     33",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H389894\">",
"    <span class=\"h2\">",
"     Bickerstaff encephalitis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bickerstaff encephalitis is a brainstem encephalitis characterized by encephalopathy and hyperreflexia with features of Miller Fisher syndrome such as ophthalmoplegia and ataxia. It is not only clinically linked to Miller Fisher syndrome, but is associated with anti-GQ1b antibodies and can respond to IVIG and plasma exchange [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/34,35\">",
"     34,35",
"    </a>",
"    ]. Some experts consider Miller Fisher syndrome, Bickerstaff encephalitis, and pharyngeal-cervical-brachial weakness with anti-GQ1b antibodies to be overlapping expressions of the anti-GQ1b antibody syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H389908\">",
"    <span class=\"h2\">",
"     Pharyngeal-cervical-brachial weakness",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pharyngeal-cervical-brachial variant of GBS is characterized by acute weakness of the oropharyngeal, neck, and shoulder muscles with swallowing dysfunction [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/37,38\">",
"     37,38",
"    </a>",
"    ]. Facial weakness may be present as well. Leg strength and leg reflexes are usually preserved. This form may overlap with Miller Fisher syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/38,39\">",
"     38,39",
"    </a>",
"    ]. It is thought to represent a localized form of axonal GBS [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/1,37,38\">",
"     1,37,38",
"    </a>",
"    ]. Some patients with pharyngeal-cervical-brachial weakness have IgG autoantibodies to GT1a, GQ1b, or less often to GD1a.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Other variants",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are a number of additional uncommon variants of GBS, including the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Acute pandysautonomia, which may respond to intravenous immune globulin [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/40,41\">",
"       40,41",
"      </a>",
"      ]. Symptoms include diarrhea, vomiting, dizziness, abdominal pain, ileus, orthostatic hypotension, urinary retention, pupillary abnormalities, an invariant heart rate, decreased sweating, salivation, and lacrimation. Reflexes are absent or diminished and sensory symptoms may be present.",
"     </li>",
"     <li>",
"      Pure sensory GBS, with involvement of large sensory fibers leading to significant sensory ataxia [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/14\">",
"       14",
"      </a>",
"      ]. Reflexes are absent and there may be minor motor involvement. An association with antibodies to GD1b has been noted [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Facial diplegia and distal limb paresthesia [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/39,42\">",
"       39,42",
"      </a>",
"      ]. This is considered a variant of acute inflammatory demyelinating polyneuropathy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/1\">",
"       1",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Sixth nerve palsy and distal paresthesia [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Bilateral lumbar radiculopathy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Paraparesis, with clinical and electrophysiological involvement limited to the legs [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     DIAGNOSTIC EVALUATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The initial diagnosis of Guillain-Barr&eacute; syndrome (GBS) is based upon the clinical presentation. As discussed above, the cardinal clinical features of GBS are progressive, mostly symmetric muscle weakness and absent or depressed deep tendon reflexes. The weakness can vary from mild difficulty with walking to nearly complete paralysis of all extremity, facial, respiratory, and bulbar muscles. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Clinical features'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The diagnosis of Guillain-Barr&eacute; syndrome (GBS) is confirmed if cerebrospinal fluid (CSF) and clinical neurophysiology studies show typical abnormalities. Therefore, lumbar puncture and clinical neurophysiology studies are performed in all patients with suspected GBS.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Cerebrospinal fluid analysis",
"    </span>",
"    &nbsp;&mdash;&nbsp;In patients with GBS, lumbar puncture often reveals an elevated CSF protein with a normal CSF white blood cell count. This finding, known as albuminocytologic dissociation, is present in 50 to 66 percent of patients with GBS in the first week after the onset of symptoms and &ge;75 percent of patients in the third week [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/1,8,43\">",
"     1,8,43",
"    </a>",
"    ]. The elevated protein may be due to increased permeability of the blood-nerve-barrier at the level of the proximal nerve roots. A normal CSF protein is found in one-third to one-half of patients when tested earlier than one week after symptom onset.",
"   </p>",
"   <p>",
"    In the Massachusetts General Hospital (MGH) prospective series of 110 patients with GBS, initial CSF protein elevations varied from 45 to 200",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (0.45 to 2.0",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    in 73 percent of patients, but protein elevations as high as 1000",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    (10",
"    <span class=\"nowrap\">",
"     g/L)",
"    </span>",
"    have been described [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    As noted, the CSF cell count is typically normal, ie, less than 5",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </span>",
"    However, a minority of patients with GBS have mildly elevated CSF cell counts. In the MGH series, the cell count was &lt;5, 5 to 10, 11 to 30, and &gt;30",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"    </span>",
"    in 87, 9, 2 and 2 percent of patients, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/8\">",
"     8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In contrast to patients with GBS who are not infected with human immunodeficiency virus (HIV), a CSF pleocytosis is common in patients who have GBS and concurrent HIV infection. Even in patients with asymptomatic HIV infection, a mild CSF pleocytosis is frequently present, as illustrated by a prospective longitudinal study of 28 patients with early HIV infection initiating antiretroviral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/44\">",
"     44",
"    </a>",
"    ]. An elevated CSF white blood cell count (mean 15",
"    <span class=\"nowrap\">",
"     cells/mm",
"     <sup>",
"      3",
"     </sup>",
"     ;",
"    </span>",
"    range 6 to 66) was present in 24 patients (86 percent), and all were asymptomatic.",
"   </p>",
"   <p>",
"    Therefore, concurrent HIV infection or an alternative diagnosis should be considered in patients with a CSF cell count",
"    <span class=\"nowrap\">",
"     &gt;10/mm",
"     <sup>",
"      3",
"     </sup>",
"     .",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Clinical neurophysiology studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Nerve conduction studies (NCS) and needle electromyography (EMG) are valuable not only for confirming the diagnosis of GBS but also for providing some information regarding prognosis.",
"   </p>",
"   <p>",
"    Both the initial diagnosis of GBS and the differential diagnosis of acute motor axonal neuropathy (AMAN) or acute motor and sensory axonal neuropathy (AMSAN) versus acute inflammatory demyelinating polyneuropathy (AIDP) can be difficult. Since the nerve conduction abnormalities progress over time, serial clinical neurophysiology studies are frequently helpful.",
"   </p>",
"   <p>",
"    Electrodiagnostic findings in patients with specific GBS variants are discussed above. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'GBS variants'",
"    </a>",
"    above.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Antibodies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Immune reactions directed against epitopes in Schwann cell surface membrane or myelin can cause the acute demyelinating form of GBS, while immune reactions against epitopes contained in the axonal membrane cause the acute axonal forms of GBS. Antibodies against GQ1b, a ganglioside component of nerve, are present in the vast majority of patients with Miller Fisher syndrome (MFS). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40038?source=see_link\">",
"     \"Pathogenesis of Guillain-Barr&eacute; syndrome in adults\"",
"    </a>",
"    and",
"    <a class=\"local\" href=\"#H4\">",
"     'GBS variants'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In clinical practice, commercially available testing for serum IgG antibodies to GQ1b is useful for the diagnosis of MFS, having a sensitivity of 85 to 90 percent. Antibodies to GQ1b may also be present in GBS with ophthalmoparesis, Bickerstaff encephalitis, and the pharyngeal-cervical brachial GBS variant, but not in disorders other than GBS [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/30,31\">",
"     30,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Currently, laboratory testing for antibodies to glycolipids other than GQ1b is not performed routinely because of limited clinical utility.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Diagnostic criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diagnostic criteria for GBS from the National Institute of Neurological Disorders and Stroke (NINDS) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/45\">",
"     45",
"    </a>",
"    ] have an important role in research and are widely used in clinical practice. These criteria are based on expert consensus.",
"   </p>",
"   <p>",
"    Required features include:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Progressive weakness of more than one limb, ranging from minimal weakness of the legs to total paralysis of all four limbs, the trunk, bulbar and facial muscles, and external ophthalmoplegia",
"     </li>",
"     <li>",
"      Areflexia. While universal areflexia is typical, distal areflexia with hyporeflexia at the knees and biceps will suffice if other features are consistent.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Supportive features include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Progression of symptoms over days to four weeks",
"     </li>",
"     <li>",
"      Relative symmetry",
"     </li>",
"     <li>",
"      Mild sensory symptoms or signs",
"     </li>",
"     <li>",
"      Cranial nerve involvement, especially bilateral facial nerve weakness",
"     </li>",
"     <li>",
"      Recovery starting two to four weeks after progression halts",
"     </li>",
"     <li>",
"      Autonomic dysfunction",
"     </li>",
"     <li>",
"      No fever at the onset",
"     </li>",
"     <li>",
"      Elevated protein in CSF with a cell count",
"      <span class=\"nowrap\">",
"       &lt;10/mm",
"       <sup>",
"        3",
"       </sup>",
"      </span>",
"     </li>",
"     <li>",
"      Electrodiagnostic abnormalities consistent with GBS",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The following features make the diagnosis of GBS doubtful:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Sensory level (decrement or loss of sensation below a spinal cord root level as determined by neurologic examination)",
"     </li>",
"     <li>",
"      Marked, persistent asymmetry of weakness",
"     </li>",
"     <li>",
"      Severe and persistent bowel and bladder dysfunction",
"     </li>",
"     <li>",
"      More than 50 white cells in the CSF",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    These diagnostic criteria have been used for years in research studies and are applicable to about 80 or 90 percent of patients with GBS in North America and Europe, particularly those with the AIDP form. Patients with GBS who do not meet the required criteria will typically have one of the other GBS variants such as AMAN, in which reflexes can be retained, MFS, or a regional variant. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'GBS variants'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In support of this observation, an epidemiologic study in Italy found that 84.3 percent of patients with GBS fulfilled the NINDS criteria and 15.7 percent had a variant syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/46\">",
"     46",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     DIFFERENTIAL DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The differential diagnosis of GBS includes other acute polyneuropathies, chronic inflammatory demyelinating polyneuropathy, and diseases of the spinal cord, neuromuscular junction, and muscle (",
"    <a class=\"graphic graphic_table graphicRef80040 \" href=\"UTD.htm?32/45/33500\">",
"     table 1",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Chronic inflammatory demyelinating polyneuropathy",
"    </span>",
"    &nbsp;&mdash;&nbsp;There is a temporal continuum between acute inflammatory demyelinating polyneuropathy (AIDP), the demyelinating form of GBS, and chronic inflammatory demyelinating polyneuropathy (CIDP).",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      AIDP is a monophasic subacute illness that reaches its nadir within three to four weeks",
"     </li>",
"     <li>",
"      CIDP continues to progress or has relapses for greater than eight weeks (see",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40472?source=see_link\">",
"       \"Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis\"",
"      </a>",
"      )",
"     </li>",
"     <li>",
"      Subacute inflammatory demyelinating polyneuropathy (SIDP) is the term used by some authors for disease that reaches its nadir between four and eight weeks",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    This arbitrary temporal delineation of inflammatory demyelinating polyneuropathy can occasionally be difficult to ascertain in practice. Only observation of the patient over time can clarify whether the clinical course is that of AIDP or CIDP.",
"   </p>",
"   <p>",
"    In addition to chronicity, other features may be useful to distinguish GBS (including AIDP) from CIDP:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      While the onset of GBS is usually easily identified, the precise onset of CIDP is typically less clear",
"     </li>",
"     <li>",
"      Antecedent events are more frequent with GBS (where they occur in approximately 70 percent of cases) than with CIDP (where they are found in &le;30 percent of cases). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40038?source=see_link&amp;anchor=H4#H4\">",
"       \"Pathogenesis of Guillain-Barr&eacute; syndrome in adults\", section on 'Antecedent events'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Certain features are more consistent with an increased likelihood of CIDP in the first weeks after onset of symptoms, including three or more episodes of clinical deterioration, a mild disease course with retained ability to walk independently, and lack of cranial neuropathies [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/47\">",
"       47",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    About 2 percent of patients initially diagnosed with AIDP will develop the chronic relapsing weakness of CIDP. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/16/265?source=see_link&amp;anchor=H24#H24\">",
"     \"Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults\", section on 'Relapses'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Other polyneuropathies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute polyneuropathies that may mimic GBS include those due to acute severe vitamin B1 deficiency, acute arsenic poisoning, n-hexane (in glue sniffing neuropathy), vasculitis, Lyme disease, tick paralysis (mostly in children), porphyria, sarcoidosis, leptomeningeal disease, paraneoplastic disease, and critical illness.",
"   </p>",
"   <p>",
"    The combination of data from the clinical setting, laboratory testing, particularly electromyography with nerve conduction studies and cerebrospinal fluid analysis, are usually sufficient to rule out these other causes of polyneuropathy.",
"   </p>",
"   <p>",
"    Peripheral nerve vasculitis is a potentially life-threatening illness that can be difficult to diagnose. The pattern is that of a mononeuritis multiplex involving sensory and motor fibers in the distribution of individual peripheral nerves. Although the pathology of the disease is asymmetric, the clinical picture can mimic GBS with fairly symmetric ascending weakness when the vasculitis is rapidly progressive with confluent nerve involvement. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=see_link\">",
"     \"Clinical manifestations of vasculitic neuropathy\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Severe pain is present in the majority of patients with peripheral nerve vasculitis. The most frequently associated conditions include polyarteritis nodosa, rheumatoid arthritis, Churg-Strauss syndrome, and connective tissue disorder not otherwise specified. Systemic features of weight loss and fever as well as other organ involvement may be present [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/48\">",
"     48",
"    </a>",
"    ]. Serological testing, detailed clinical electrophysiologic testing, and biopsy of nerve and muscle lead to the diagnosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Spinal cord disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute myelopathies due to spinal cord compression or acute transverse myelitis can be confused with GBS, since reflexes can be depressed in the acute stage of spinal cord disease. Early bowel and bladder dysfunction and a sensory level point to a myelopathy. Magnetic resonance imaging (MRI) is usually helpful in diagnosing acute myelopathy by demonstrating a focal spinal cord lesion.",
"   </p>",
"   <p>",
"    Severe low back pain in patients with GBS is common and frequently leads to imaging of the lumbar spine; practitioners should be aware that prominent contrast enhancement of the nerve roots on MRI may occur in GBS [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/49\">",
"     49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Neuromuscular junction disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Diseases of the neuromuscular junction including botulism, myasthenia gravis, and Lambert-Eaton myasthenic syndrome can all present with acute weakness, but sensory signs or symptoms are lacking. Botulism is associated with large, unreactive pupils and constipation. Electromyography testing with repetitive nerve stimulation and appropriate laboratory tests help clarify the diagnosis. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=see_link\">",
"     \"Diagnosis of myasthenia gravis\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35992?source=see_link\">",
"     \"Clinical features and diagnosis of Lambert-Eaton myasthenic syndrome\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=see_link\">",
"     \"Botulism\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Muscle disorders",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute polymyositis, critical illness myopathy, and critical illness neuropathy can occasionally mimic GBS. The myopathy and neuropathy of critical illness present as an acute paralysis, typically in patients receiving intensive care. High-dose intravenous corticosteroids, neuromuscular blocking drugs, sepsis, and multiorgan failure are thought to play an important role, but the pathophysiology is not well understood. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/60/43976?source=see_link\">",
"     \"Neuromuscular weakness related to critical illness\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In critical illness neuropathy, clinical electrophysiological testing shows markedly reduced motor and sensory responses with widespread active denervation.",
"     </li>",
"     <li>",
"      In critical illness myopathy, the sensory responses are spared.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Differential diagnosis of Miller Fisher syndrome",
"    </span>",
"    &nbsp;&mdash;&nbsp;On initial presentation, Miller Fisher syndrome (MFS) may be mistaken for a brainstem stroke. However, the gradual onset of MFS in particular distinguishes this syndrome clinically from an acute stroke. The differential diagnosis of MFS includes Wernicke's encephalopathy and brainstem encephalitis, but these are associated with altered mental status. In addition, patients with Wernicke's encephalopathy usually have nystagmus, a feature not associated with MFS.",
"   </p>",
"   <p>",
"    Other entities to consider in the differential diagnosis of MFS are myasthenia gravis and other neuromuscular junction disorders. Appropriate laboratory and clinical electrophysiological testing with repetitive nerve stimulation helps differentiate MFS from a neuromuscular junction disorder.",
"   </p>",
"   <p>",
"    The combination of absent or reduced sensory responses on clinical electrophysiology testing [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/32\">",
"     32",
"    </a>",
"    ] and elevated CSF protein lead to the diagnosis of MFS. The diagnosis of MFS can be confirmed by positive anti-GQ1b antibody testing [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5481/abstract/30\">",
"     30",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Basics topics (see",
"      <a class=\"medical medical_basics\" href=\"UTD.htm?36/37/37457?source=see_link\">",
"       \"Patient information: Guillain-Barr&eacute; syndrome (The Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The Guillain-Barr&eacute; syndrome (GBS) is an acute monophasic illness causing a rapidly progressive polyneuropathy with weakness or paralysis.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The cardinal clinical features of GBS are progressive, mostly symmetric muscle weakness and absent or depressed deep tendon reflexes. The weakness can vary from mild difficulty with walking to nearly complete paralysis of all extremity, facial, respiratory, and bulbar muscles. Severe respiratory muscle weakness necessitating ventilatory support develops in about 30 percent, and dysautonomia occurs in 70 percent of patients. GBS usually progresses over a period of about two weeks. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Clinical features'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      GBS is a heterogeneous syndrome with several variant forms. Acute inflammatory demyelinating polyneuropathy (AIDP) is the most common variant of GBS in North America, Europe, and most of the developed world. The Miller Fisher syndrome (MFS) is a GBS variant characterized by ophthalmoplegia with ataxia and areflexia. (See",
"      <a class=\"local\" href=\"#H4\">",
"       'GBS variants'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H5\">",
"       'Acute inflammatory demyelinating polyneuropathy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H389462\">",
"       'Miller Fisher syndrome'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Axonal forms of GBS include acute motor axonal neuropathy (AMAN), most common in Japan and China, and acute motor and sensory axonal neuropathy (AMSAN). (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Acute motor axonal neuropathy'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H8\">",
"       'Acute motor and sensory axonal neuropathy'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The initial diagnosis of GBS is based upon the clinical presentation. The diagnosis is confirmed by cerebrospinal fluid (CSF) analysis and clinical neurophysiology studies. Therefore, these studies should be performed in all patients with suspected GBS. (See",
"      <a class=\"local\" href=\"#H10\">",
"       'Diagnostic evaluation'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      An increased CSF protein with a normal CSF white blood cell count (albuminocytologic dissociation) is found in 50 to 66 percent of patients with GBS in the first week after the onset of symptoms and in &ge;75 percent of patients in the third week. An alternative diagnosis, particularly human immunodeficiency virus, should be considered in patients with a CSF cell count",
"      <span class=\"nowrap\">",
"       &gt;10/mm",
"       <sup>",
"        3",
"       </sup>",
"       .",
"      </span>",
"      (See",
"      <a class=\"local\" href=\"#H11\">",
"       'Cerebrospinal fluid analysis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Clinical neurophysiology studies show evidence of acute polyneuropathy with either predominantly demyelinating (AIDP) or axonal (AMAN, AMSAN) features. (See",
"      <a class=\"local\" href=\"#H12\">",
"       'Clinical neurophysiology studies'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H4\">",
"       'GBS variants'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Testing for serum IgG antibodies to GQ1b is useful for the diagnosis of MFS. Testing for other glycolipid antibodies has no clinical role. (See",
"      <a class=\"local\" href=\"#H13\">",
"       'Antibodies'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The differential diagnosis of GBS includes other acute polyneuropathies, chronic inflammatory demyelinating polyneuropathy, and diseases of the spinal cord, neuromuscular junction, and muscle. The differential diagnosis of the MFS variant of GBS includes brainstem stroke, Wernicke's encephalopathy, and brainstem encephalitis. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Differential diagnosis'",
"      </a>",
"      above and",
"      <a class=\"local\" href=\"#H21\">",
"       'Differential diagnosis of Miller Fisher syndrome'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/1\">",
"      Yuki N, Hartung HP. Guillain-Barr&eacute; syndrome. N Engl J Med 2012; 366:2294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/2\">",
"      Sejvar JJ, Baughman AL, Wise M, Morgan OW. Population incidence of Guillain-Barr&eacute; syndrome: a systematic review and meta-analysis. Neuroepidemiology 2011; 36:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/3\">",
"      Ropper AH. The Guillain-Barr&eacute; syndrome. N Engl J Med 1992; 326:1130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/4\">",
"      Alshekhlee A, Hussain Z, Sultan B, Katirji B. Guillain-Barr&eacute; syndrome: incidence and mortality rates in US hospitals. Neurology 2008; 70:1608.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/5\">",
"      Moulin DE, Hagen N, Feasby TE, et al. Pain in Guillain-Barr&eacute; syndrome. Neurology 1997; 48:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/6\">",
"      Ruts L, Drenthen J, Jongen JL, et al. Pain in Guillain-Barre syndrome: a long-term follow-up study. Neurology 2010; 75:1439.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/7\">",
"      Zochodne DW. Autonomic involvement in Guillain-Barr&eacute; syndrome: a review. Muscle Nerve 1994; 17:1145.",
"     </a>",
"    </li>",
"    <li>",
"     Ropper AH, Wijdicks EFM, Truax BT. Guillain-Barr&eacute; syndrome, FA Davis, Philadelphia 1991. p.57.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/9\">",
"      Hochman MS, Kobetz SA, Handwerker JV. Inappropriate secretion of antidiuretic hormone associated with Guillain-Barr&eacute; syndrome. Ann Neurol 1982; 11:322.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/10\">",
"      Kaneko K, Shioya T, Yabuta K. Inappropriate secretion of antidiuretic hormone and transient hypertension associated with Guillain-Barr&eacute; syndrome. Pediatr Neurosci 1989; 15:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/11\">",
"      Hoffmann O, Reuter U, Schielke E, Weber JR. SIADH as the first symptom of Guillain-Barr&eacute; syndrome. Neurology 1999; 53:1365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/12\">",
"      Saifudheen K, Jose J, Gafoor VA, Musthafa M. Guillain-Barre syndrome and SIADH. Neurology 2011; 76:701.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/13\">",
"      Nagashima T, Koga M, Odaka M, et al. Clinical correlates of serum anti-GT1a IgG antibodies. J Neurol Sci 2004; 219:139.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/14\">",
"      Wicklein EM, Pfeiffer G, Yuki N, et al. Prominent sensory ataxia in Guillain-Barr&eacute; syndrome associated with IgG anti-GD1b antibody. J Neurol Sci 1997; 151:227.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/15\">",
"      FISHER M. An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia). N Engl J Med 1956; 255:57.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/16\">",
"      McKhann GM, Cornblath DR, Griffin JW, et al. Acute motor axonal neuropathy: a frequent cause of acute flaccid paralysis in China. Ann Neurol 1993; 33:333.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/17\">",
"      Kimura J. Proximal versus distal slowing of motor nerve conduction velocity in the Guillain-Barr&eacute; syndrome. Ann Neurol 1978; 3:344.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/18\">",
"      Gordon PH, Wilbourn AJ. Early electrodiagnostic findings in Guillain-Barr&eacute; syndrome. Arch Neurol 2001; 58:913.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/19\">",
"      Sumner AJ. The physiological basis for symptoms in Guillain-Barr&eacute; syndrome. Ann Neurol 1981; 9 Suppl:28.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/20\">",
"      Albers JW, Donofrio PD, McGonagle TK. Sequential electrodiagnostic abnormalities in acute inflammatory demyelinating polyradiculoneuropathy. Muscle Nerve 1985; 8:528.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/21\">",
"      Murray NM, Wade DT. The sural sensory action potential in Guillain-Barr&eacute; syndrome. Muscle Nerve 1980; 3:444.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/22\">",
"      Cornblath DR, Mellits ED, Griffin JW, et al. Motor conduction studies in Guillain-Barr&eacute; syndrome: description and prognostic value. Ann Neurol 1988; 23:354.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/23\">",
"      Feasby TE, Gilbert JJ, Brown WF, et al. An acute axonal form of Guillain-Barr&eacute; polyneuropathy. Brain 1986; 109 ( Pt 6):1115.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/24\">",
"      Ho TW, Mishu B, Li CY, et al. Guillain-Barr&eacute; syndrome in northern China. Relationship to Campylobacter jejuni infection and anti-glycolipid antibodies. Brain 1995; 118 ( Pt 3):597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/25\">",
"      Ho TW, Li CY, Cornblath DR, et al. Patterns of recovery in the Guillain-Barre syndromes. Neurology 1997; 48:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/26\">",
"      Kuwabara S, Yuki N, Koga M, et al. IgG anti-GM1 antibody is associated with reversible conduction failure and axonal degeneration in Guillain-Barr&eacute; syndrome. Ann Neurol 1998; 44:202.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/27\">",
"      Griffin JW, Li CY, Ho TW, et al. Pathology of the motor-sensory axonal Guillain-Barr&eacute; syndrome. Ann Neurol 1996; 39:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/28\">",
"      Lo YL. Clinical and immunological spectrum of the Miller Fisher syndrome. Muscle Nerve 2007; 36:615.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/29\">",
"      Lee SH, Lim GH, Kim JS, et al. Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody. Neurology 2008; 71:426.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/30\">",
"      Chiba A, Kusunoki S, Obata H, et al. Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barr&eacute; syndrome: clinical and immunohistochemical studies. Neurology 1993; 43:1911.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/31\">",
"      Willison HJ, Veitch J, Paterson G, Kennedy PG. Miller Fisher syndrome is associated with serum antibodies to GQ1b ganglioside. J Neurol Neurosurg Psychiatry 1993; 56:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/32\">",
"      Fross RD, Daube JR. Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings. Neurology 1987; 37:1493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/33\">",
"      Phillips MS, Stewart S, Anderson JR. Neuropathological findings in Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 1984; 47:492.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/34\">",
"      Winer JB. Bickerstaff's encephalitis and the Miller Fisher syndrome. J Neurol Neurosurg Psychiatry 2001; 71:433.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/35\">",
"      Odaka M, Yuki N, Hirata K. Anti-GQ1b IgG antibody syndrome: clinical and immunological range. J Neurol Neurosurg Psychiatry 2001; 70:50.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/36\">",
"      Shahrizaila N, Yuki N. Bickerstaff brainstem encephalitis and Fisher syndrome: anti-GQ1b antibody syndrome. J Neurol Neurosurg Psychiatry 2012.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/37\">",
"      Ropper AH. Unusual clinical variants and signs in Guillain-Barr&eacute; syndrome. Arch Neurol 1986; 43:1150.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/38\">",
"      Nagashima T, Koga M, Odaka M, et al. Continuous spectrum of pharyngeal-cervical-brachial variant of Guillain-Barr&eacute; syndrome. Arch Neurol 2007; 64:1519.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/39\">",
"      Ropper AH. Further regional variants of acute immune polyneuropathy. Bifacial weakness or sixth nerve paresis with paresthesias, lumbar polyradiculopathy, and ataxia with pharyngeal-cervical-brachial weakness. Arch Neurol 1994; 51:671.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/40\">",
"      Mericle RA, Triggs WJ. Treatment of acute pandysautonomia with intravenous immunoglobulin. J Neurol Neurosurg Psychiatry 1997; 62:529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/41\">",
"      Koike H, Atsuta N, Adachi H, et al. Clinicopathological features of acute autonomic and sensory neuropathy. Brain 2010; 133:2881.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/42\">",
"      Susuki K, Koga M, Hirata K, et al. A Guillain-Barr&eacute; syndrome variant with prominent facial diplegia. J Neurol 2009; 256:1899.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/43\">",
"      Nishimoto Y, Odaka M, Hirata K, Yuki N. Usefulness of anti-GQ1b IgG antibody testing in Fisher syndrome compared with cerebrospinal fluid examination. J Neuroimmunol 2004; 148:200.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/44\">",
"      Spudich SS, Nilsson AC, Lollo ND, et al. Cerebrospinal fluid HIV infection and pleocytosis: relation to systemic infection and antiretroviral treatment. BMC Infect Dis 2005; 5:98.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/45\">",
"      Criteria for diagnosis of Guillain-Barr&eacute; syndrome. Ann Neurol 1978; 3:565.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/46\">",
"      Govoni V, Granieri E, Tola MR, et al. The frequency of clinical variants of Guillain-Barr&eacute; syndrome in Ferrara, Italy. J Neurol 1999; 246:1010.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/47\">",
"      Ruts L, Drenthen J, Jacobs BC, et al. Distinguishing acute-onset CIDP from fluctuating Guillain-Barre syndrome: a prospective study. Neurology 2010; 74:1680.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/48\">",
"      Kissel JT, Mendell JR. Vasculitic neuropathy. Neurol Clin 1992; 10:761.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5481/abstract/49\">",
"      Perry JR, Fung A, Poon P, Bayer N. Magnetic resonance imaging of nerve root inflammation in the Guillain-Barr&eacute; syndrome. Neuroradiology 1994; 36:139.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 5137 Version 9.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.3 - C21.34",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     Morehouse School of Medicine",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-200.150.3.100-CF9877BBA9-S473950.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5481=[""].join("\n");
var outline_f5_22_5481=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H22\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H284586891\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Laboratory features",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      GBS VARIANTS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Acute inflammatory demyelinating polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Acute motor axonal neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Acute motor and sensory axonal neuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H389462\">",
"      Miller Fisher syndrome",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H389894\">",
"      Bickerstaff encephalitis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H389908\">",
"      Pharyngeal-cervical-brachial weakness",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Other variants",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      DIAGNOSTIC EVALUATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Cerebrospinal fluid analysis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Clinical neurophysiology studies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Antibodies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Diagnostic criteria",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      DIFFERENTIAL DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Chronic inflammatory demyelinating polyneuropathy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Other polyneuropathies",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Spinal cord disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Neuromuscular junction disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Muscle disorders",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Differential diagnosis of Miller Fisher syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/5137\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/5137|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?32/45/33500\" title=\"table 1\">",
"      Differential diagnosis of GBS",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?36/36/37448?source=related_link\">",
"      Botulism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/33/40472?source=related_link\">",
"      Chronic inflammatory demyelinating polyneuropathy: Etiology, clinical features, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?35/9/35992?source=related_link\">",
"      Clinical features and diagnosis of Lambert-Eaton myasthenic syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?21/57/22423?source=related_link\">",
"      Clinical manifestations of vasculitic neuropathy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?32/12/32968?source=related_link\">",
"      Diagnosis of myasthenia gravis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/60/43976?source=related_link\">",
"      Neuromuscular weakness related to critical illness",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/3/27705?source=related_link\">",
"      Overview of Guillain-Barr&eacute; syndrome in children",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/6/40038?source=related_link\">",
"      Pathogenesis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_basics\" href=\"UTD.htm?36/37/37457?source=related_link\">",
"      Patient information: Guillain-Barr&eacute; syndrome (The Basics)",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/16/265?source=related_link\">",
"      Treatment and prognosis of Guillain-Barr&eacute; syndrome in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?40/51/41781?source=related_link\">",
"      Treatment of Guillain-Barr&eacute; syndrome in children",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_22_5482="Bone marrow aspiration and biopsy: Indications and technique";
var content_f5_22_5482=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Bone marrow aspiration and biopsy: Indications and technique",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/22/5482/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5482/contributors\">",
"     James L Zehnder, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/22/5482/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5482/contributors\">",
"     Stanley L Schrier, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?5/22/5482/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?5/22/5482/contributors\">",
"     Stephen A Landaw, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?5/22/5482/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Apr 10, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow examination is useful in the diagnosis and staging of hematologic disease, as well as in the assessment of overall bone marrow cellularity. Because of easy accessibility, aspiration, biopsy, and culture of the bone marrow may also play a role in the assessment of patients with fever of undetermined origin as well as in the diagnosis of various storage and infiltrative disorders.",
"   </p>",
"   <p>",
"    The indications, contraindications, technique, and complications of bone marrow aspiration and biopsy will be reviewed here [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/1\">",
"     1",
"    </a>",
"    ]. Evaluation of bone marrow aspirates and biopsies is presented separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=see_link\">",
"     \"Evaluation of bone marrow aspirate smears\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     BACKGROUND INFORMATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;The bone marrow is one of the most widely distributed organs in the human body. It is the principal site of blood formation beginning at the time of birth, at which time all bone cavities are filled with hematopoietic tissue. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?24/34/25129?source=see_link&amp;anchor=H2#H2\">",
"     \"Overview of hematopoiesis and stem cell function\", section on 'Bone marrow anatomy and microenvironment'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    By adolescence, active marrow is usually only found in the cavities of axial bones (sternum, ribs, vertebrae, clavicles, scapulae, skull, pelvis, and the proximal ends of the femurs and humeri) (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef74577 \" href=\"UTD.htm?27/2/27682\">",
"     image 1",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. Overall bone marrow cellularity approximates 100 percent at birth and declines with time, paralleling an age-associated reduction in hematopoietic activity. Accordingly, bone marrow cellularity in the normal adult is approximately 50 percent, with the remainder of the marrow being composed of adipose tissue (",
"    <a class=\"graphic graphic_picture graphicRef68384 \" href=\"UTD.htm?27/53/28500\">",
"     picture 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=see_link&amp;anchor=H8#H8\">",
"     \"Evaluation of bone marrow aspirate smears\", section on 'Estimation of cellularity and myeloid to erythroid ratio'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Under physiologic conditions, all sites of hematopoiesis tend to exhibit uniform cellularity and cell lineage proportions. Thus, generalizations can be made regarding overall hematopoiesis from the evaluation of bone marrow at a single site. In most hematologic disorders, study of bone marrow at multiple sites has not been shown to improve diagnostic accuracy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/2\">",
"     2",
"    </a>",
"    ]. Exceptions include malignancies which may have patchy marrow involvement (eg, multiple myeloma, lymphoma, metastatic disease), requiring either larger specimens or specimens from multiple sites (see",
"    <a class=\"local\" href=\"#H12\">",
"     'Adequacy of the biopsy specimen'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h1\">",
"     INDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The decision to subject a patient to bone marrow evaluation must be made after the critical assessment of pertinent information available from the history, physical, and laboratory studies, including a review of the complete blood count and examination of the peripheral blood smear. As noted above, bone marrow examination is a useful tool in the diagnosis and staging of various hematologic diseases and in the assessment of bone marrow cellularity, cellular morphology, and maturation. Highly specialized testing, such as cytogenetic, immunophenotypic, and molecular analyses, can be performed on these specimens, and have become critically important in establishing certain diagnoses, especially the leukemias and lymphomas [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3,4\">",
"     3,4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H25#H25\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Studies on excised tissue'",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/58/20393?source=see_link&amp;anchor=H20#H20\">",
"     \"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia\", section on 'Diagnosis'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In addition to accommodating blood cell formation, the bone marrow also houses a complex stromal complex, along with elements of the monocyte-macrophage system. These supporting cellular systems may also become involved in a number of systemic diseases. Accordingly, aspiration, biopsy, and culture of the bone marrow may have value in the assessment of patients with fever of undetermined origin and in the diagnosis of various storage and infiltrative diseases, in which the number",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    activity of these stromal cells may be deranged (see below).",
"   </p>",
"   <p>",
"    Most clinical scenarios require both bone marrow aspiration and biopsy for a complete hematologic evaluation. This is especially true when assessing overall bone marrow cellularity, determining patterns of marrow involvement, and searching for evidence of infiltration associated with Hodgkin and non-Hodgkin lymphoma, solid malignancies, or storage diseases. Accordingly, bone marrow aspiration is most often accompanied by biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/5-8\">",
"     5-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Exceptions to this rule are circumstances in which a very specific clinical question can be answered via aspiration alone. An example might be in the diagnosis and follow-up of chronic myeloid leukemia (CML), as the diagnosis relies heavily on cytogenetic and molecular findings, as well as morphology, all of which can be obtained by aspiration or by sampling peripheral blood [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/4\">",
"     4",
"    </a>",
"    ]. However, even this is controversial, as some cases of CML may be accompanied by fibrosis, which is best assessed on the biopsy specimen. Aspiration alone may be adequate for the initial diagnosis of acute myeloid leukemia (AML), as well as routine surveillance bone marrow examinations on these patients [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/4\">",
"     4",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12073?source=see_link\">",
"     \"Remission criteria in acute myeloid leukemia and monitoring for residual disease\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Indications for bone marrow evaluation fall into several categories (",
"    <a class=\"graphic graphic_table graphicRef66404 \" href=\"UTD.htm?31/2/31787\">",
"     table 1",
"    </a>",
"    ):",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evaluation of unexplained anemia, leukopenia, thrombocytopenia, or pancytopenia. Bone marrow aspiration and biopsy may not have diagnostic utility in the evaluation of younger patients, especially children, with isolated thrombocytopenia, felt to be consistent with immune thrombocytopenia (ITP) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/9\">",
"       9",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=see_link&amp;anchor=H49#H49\">",
"       \"Approach to the adult patient with anemia\", section on 'Bone marrow examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?24/2/24614?source=see_link&amp;anchor=H2#H2\">",
"       \"Laboratory evaluation of neutropenia and neutrophil dysfunction\", section on 'Laboratory approach to the neutropenic patient'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=see_link&amp;anchor=H35#H35\">",
"       \"Approach to the adult patient with thrombocytopenia\", section on 'Bone marrow examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30938?source=see_link&amp;anchor=H20#H20\">",
"       \"Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in adults\", section on 'Bone marrow aspiration and biopsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Diagnosis and staging of lymphoma or solid tumors. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H29#H29\">",
"       \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Bone marrow examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=see_link&amp;anchor=H10#H10\">",
"       \"Pathobiology and staging of small cell carcinoma of the lung\", section on 'Staging workup'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of elevated peripheral counts (eg, polycythemia, thrombocytosis, leukocytosis).",
"     </li>",
"     <li>",
"      Diagnosis and evaluation of plasma cell disorders and leukemias. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=see_link&amp;anchor=H18#H18\">",
"       \"Clinical features, laboratory manifestations, and diagnosis of multiple myeloma\", section on 'Bone marrow examination'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?19/58/20393?source=see_link&amp;anchor=H14#H14\">",
"       \"Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia\", section on 'Bone marrow biopsy and aspirate'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of iron metabolism and stores. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=see_link&amp;anchor=H30#H30\">",
"       \"Causes and diagnosis of anemia due to iron deficiency\", section on 'Bone marrow iron'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of suspected deposition and storage diseases (eg, amyloidosis, Gaucher disease). (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35815?source=see_link&amp;anchor=H6#H6\">",
"       \"Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases\", section on 'Pathogenesis'",
"      </a>",
"      and",
"      <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9402?source=see_link&amp;anchor=H22#H22\">",
"       \"Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis\", section on 'Diagnosis'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of fever of undetermined origin, suspected mycobacterial, fungal, or parasitic infections, or granulomatous diseases. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31927?source=see_link&amp;anchor=H20#H20\">",
"       \"Approach to the adult with fever of unknown origin\", section on 'Biopsy'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Unexplained splenomegaly. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?33/34/34346?source=see_link&amp;anchor=H31#H31\">",
"       \"Approach to the adult patient with splenomegaly and other splenic disorders\", section on 'Additional approaches'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Evaluation of suspected chromosomal disorders in neonates. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=see_link&amp;anchor=H30#H30\">",
"       \"Approach to congenital malformations\", section on 'Laboratory studies'",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Confirmation that the bone marrow is normal in a potential allogeneic hematopoietic cell donor. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?25/38/26218?source=see_link\">",
"       \"Donor selection for hematopoietic cell transplantation\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     CONTRAINDICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;The only absolute contraindications to performing a bone marrow biopsy are the presence of hemophilia, severe disseminated intravascular coagulopathy, or other related severe bleeding disorders. Thrombocytopenia, regardless of severity, is not a contraindication [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/10,11\">",
"     10,11",
"    </a>",
"    ]. However, depending on the circumstances, platelet transfusion to insure a platelet count",
"    <span class=\"nowrap\">",
"     &gt;20,000/microL",
"    </span>",
"    may be warranted prior to the procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/12\">",
"     12",
"    </a>",
"    ], although practice patterns in this regard vary widely [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/13\">",
"     13",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Patients with suspected multiple myeloma or other disorders associated with bone resorption should not undergo sternal bone marrow aspiration due to an increased risk of sternal perforation. Bone marrow biopsy of the sternum should",
"    <strong>",
"     never",
"    </strong>",
"    be attempted in any patient, due to the fragility of the bone at this site as well as its proximity to the heart and great vessels.",
"   </p>",
"   <p>",
"    Precautions may need to be taken if there is skin infection or osteomyelitis in the area of proposed aspiration or biopsy, or if the patient is uncooperative (see below). Several complications may accompany bone marrow aspiration or biopsy despite adherence to these precautions (see",
"    <a class=\"local\" href=\"#H31\">",
"     'Complications'",
"    </a>",
"    below).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h1\">",
"     ADVANCED PREPARATION",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of important issues need to be resolved before the procedure is undertaken, including choice of the biopsy site, use of premedications and the need for an assistant, as well as determining the need and preparation necessary for specialized tests to be performed on the marrow specimens. A discussion should be had with the hematopathology laboratory before the procedure is undertaken to make sure that the appropriate samples, sample collection vials, and tests have been agreed upon.",
"   </p>",
"   <p>",
"    As with all procedures, signed informed consent must be obtained in advance from the patient, parent, or health care proxy, as appropriate.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h2\">",
"     Choice of aspiration or biopsy site",
"    </span>",
"    &nbsp;&mdash;&nbsp;The iliac crest is the only site at which both aspiration and biopsy may be safely performed in the adult.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The posterior superior iliac crest and spine (",
"      <a class=\"graphic graphic_figure graphicRef78950 \" href=\"UTD.htm?15/51/16177\">",
"       figure 1",
"      </a>",
"      ) is the favored site of examination in the adult, as well as in the child and in most infants. This site also provides the least discomfort to the patient compared with other sites.",
"     </li>",
"     <li>",
"      The anterior iliac crest (",
"      <a class=\"graphic graphic_figure graphicRef51068 \" href=\"UTD.htm?16/62/17382\">",
"       figure 2",
"      </a>",
"      ) may be used for bone marrow aspiration and biopsy in adults when access to the posterior iliac crest is limited (eg, the patient is unable to be moved for proper access to the chosen aspiration site, morbid obesity, skin diseases, or previous radiation) [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/2,10\">",
"       2,10",
"      </a>",
"      ]. An initial attempt to sample the posterior iliac bone may be worthwhile, even in neonates.",
"     </li>",
"     <li>",
"      In selected cases, bone marrow may be obtained from the greater trochanter of the femur, individual vertebral bodies, or ribs. Such procedures, including open bone biopsies, are best obtained through surgical consultation, and may require CT guidance (see",
"      <a class=\"local\" href=\"#H21\">",
"       'Surgical biopsy'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Obtaining bone marrow from a site which has been previously irradiated is likely to yield suboptimal results, especially in terms of overall cellularity. Another site should be chosen if at all possible.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Bone marrow may be aspirated from the sternum (",
"    <a class=\"graphic graphic_figure graphicRef53887 \" href=\"UTD.htm?35/21/36183\">",
"     figure 3",
"    </a>",
"    ), although",
"    <strong>",
"     biopsy at this site is contraindicated",
"    </strong>",
"    because of its minimal thickness. Special care needs to be taken if this site is chosen for marrow aspiration, since penetration of the inner table of the sternum or penetration through a rib interspace may lead to fatal hemorrhage (see",
"    <a class=\"local\" href=\"#H31\">",
"     'Complications'",
"    </a>",
"    below).",
"   </p>",
"   <p>",
"    In premature infants and some full-term infants, the iliac bone has not completely ossified, and an alternative bone (eg, the anterior portion of the tibia) should be used [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/14\">",
"     14",
"    </a>",
"    ]. If the anterior tibia must be entered, it should only be used for aspiration and limited to infants younger than 18 months of age.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h3\">",
"     The extremely obese patient",
"    </span>",
"    &nbsp;&mdash;&nbsp;On occasion, it may not be possible to identify an",
"    <span class=\"nowrap\">",
"     aspiration/biopsy",
"    </span>",
"    site because of the presence of excessive adipose tissue; surface landmarks may be difficult to identify",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    the available needle may not reach the bone surface (see",
"    <a class=\"local\" href=\"#H15\">",
"     'Technique'",
"    </a>",
"    below and",
"    <a class=\"local\" href=\"#H10\">",
"     'Needle selection'",
"    </a>",
"    below). If these maneuvers have failed, one solution is to perform the procedure using computed tomography (CT) guidance [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/15\">",
"     15",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Premedications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The pain perceived by the patient during bone marrow aspiration and biopsy performed under local anesthesia is low to moderate, being approximately 3 on a zero to 10 scale in one study [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/16\">",
"     16",
"    </a>",
"    ] and 1.7 on a zero to 5 scale in another [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/17\">",
"     17",
"    </a>",
"    ]. While premedications, including anxiolytics or opiates, are not usually necessary [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/18\">",
"     18",
"    </a>",
"    ], certain individuals with underlying dense bone structure, pain issues, or those with heightened anxiety may benefit from the use of such agents. It cannot be overstated that the quality of the specimen obtained may be vastly superior in a cooperative and comfortable patient.",
"   </p>",
"   <p>",
"    In children with procedure phobias, the use of",
"    <a class=\"drug drug_general\" href=\"UTD.htm?8/8/8329?source=see_link\">",
"     lorazepam",
"    </a>",
"    under carefully controlled conditions can be very beneficial, producing both relaxation and antegrade amnesia; lorazepam or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?41/50/42792?source=see_link\">",
"     tramadol",
"    </a>",
"    may have a similar effect in adults with anxiety [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/19-22\">",
"     19-22",
"    </a>",
"    ]. This can be particularly helpful if the child or anxious adult is likely to require multiple bone marrow evaluations over a period of time, as in the treatment of acute leukemia. A safe conscious sedation policy should be in place prior to using drugs such as benzodiazepines or opioids in patients of any age.",
"   </p>",
"   <p>",
"    The use of inhaled",
"    <a class=\"drug drug_general\" href=\"UTD.htm?11/29/11732?source=see_link\">",
"     nitrous oxide",
"    </a>",
"    and oxygen, an established combination used for pain management and sedation in certain gynecologic procedures and in sigmoidoscopy, is both well-tolerated and effective for use during bone marrow aspiration and biopsy; use of this agent may diminish the risk of prolonged sedation associated with benzodiazepine or opioid dosing [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/23-25\">",
"     23-25",
"    </a>",
"    ]. However, given the limited nature of these studies, further research may be required before the use of nitrous",
"    <span class=\"nowrap\">",
"     oxide/oxygen",
"    </span>",
"    is accepted into standard practice.",
"   </p>",
"   <p>",
"    Any premedications should be administered in a timely fashion, prior to performing the procedure, in order to allow for the desired effects [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/21,22\">",
"     21,22",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=see_link\">",
"     \"Procedural sedation in children outside of the operating room\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     Use of an assistant",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow aspirates and biopsies often clot within minutes of being obtained. During this time, the person performing the procedure may still be busy performing an aspiration or biopsy at the same or another site, reassuring the patient, or initiating local hemostasis. It is therefore important that bone marrow aspiration and biopsy be carried out with the help of a trained assistant who can either help prepare the slides and specimens or who assist in achieving adequate hemostasis following completion of the procedure.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Needle selection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Disposable aspiration and biopsy needles are preferred in order to guarantee sterility and sharpness, as well as to reduce procedure-related pain and \"failure\" rates [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/26\">",
"     26",
"    </a>",
"    ]. All commercially available needles are acceptable for aspiration and biopsy of the iliac crest. For sternal aspiration, the needle should have a guard which screws securely to a selected portion of the needle in order to limit its penetration (see",
"    <a class=\"local\" href=\"#H19\">",
"     'Sternal aspiration'",
"    </a>",
"    below). Occasionally, in obese or large patients, it may be necessary to use a trephine biopsy needle for both the aspiration and biopsy at the iliac crest, as this needle tends to be longer than a standard aspiration needle.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Sequence of aspiration and biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Although the techniques used for obtaining bone marrow aspiration and biopsy samples have been fairly well standardized, there has been some debate as to the sequence of aspiration and biopsy:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Prior studies have demonstrated artifactual reduction in overall cellularity of the bone marrow sample due to acute intramedullary hemorrhage in the biopsy specimen when aspiration was followed by biopsy [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/27\">",
"       27",
"      </a>",
"      ]. This effect was shown to be overcome by obtaining a longer, deeper specimen which bypasses the aspiration site [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/28\">",
"       28",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Alternatively, biopsy followed by aspiration could lead to premature clotting of the aspirated specimen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Despite these issues, it is generally felt that high quality specimens can be obtained, regardless of the order, provided that separate needles and separate sites (one to two centimeters apart along the iliac crest) are used for each procedure [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/28\">",
"     28",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Adequacy of the biopsy specimen",
"    </span>",
"    &nbsp;&mdash;&nbsp;Biopsies consisting mostly of cortical bone, cartilage, or muscle, without sufficient sampling of the medullary cavity are inadequate for proper evaluation. Most laboratories require a sample at least 5 mm in length. In some cases, more extensive sampling may be required.",
"   </p>",
"   <p>",
"    Obtaining an adequate biopsy from a single site in a patient with non-Hodgkin lymphoma (NHL) has been deemed inadequate by a number of studies. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=see_link&amp;anchor=H29#H29\">",
"     \"Clinical presentation and diagnosis of non-Hodgkin lymphoma\", section on 'Bone marrow examination'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An early study involving 282 patients with lymphoma and other neoplastic diseases revealed accurate diagnosis with unilateral biopsy in only 22 percent of patients with NHL, 43 percent of patients with Hodgkin lymphoma, and 36 percent of those with other neoplastic processes [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/29\">",
"       29",
"      </a>",
"      ]. The investigators concluded that bilateral sampling could yield an additional 11 to 22 percent of positive biopsies.",
"     </li>",
"     <li>",
"      Another study, including 170 specimens from 145 patients, found that accurate diagnosis improved 26 percent when bilateral specimens were obtained [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/30\">",
"       30",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      A third study of 260 patients with NHL revealed that 30 percent of positive marrows had unilateral involvement only, supporting the need for bilateral sampling [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/31\">",
"       31",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, adequate length of a unilateral biopsy may obviate the need for bilateral examination:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one study, a biopsy length of 19.5 mm was the smallest acceptable length, leading to a 50 percent chance of detecting bone marrow metastases [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/32\">",
"       32",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Another study concluded that one 20 mm-long specimen could obviate the need for bilateral bone marrow sampling in patients being evaluated for the presence of diffuse large B-cell NHL [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/33\">",
"       33",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     The dry tap",
"    </span>",
"    &nbsp;&mdash;&nbsp;A \"dry tap\" is defined by a situation in which no bone marrow sample is obtainable by aspiration (ie, there are no identifiable bone spicules in the specimen) despite easily obtained marrow blood. Faulty technique may be the cause, in that the tip of the aspirating needle may not have penetrated into the marrow cavity.",
"   </p>",
"   <p>",
"    More often, a dry tap is due to alterations within the marrow associated with myeloproliferative or leukemic disorders. Such marrow changes usually involve an element of fibrosis, metastatic tumor infiltration, or granuloma formation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/5\">",
"     5",
"    </a>",
"    ]. In such cases, bone marrow biopsy should always be performed. Touch preparations of the biopsy can be made which will often provide sufficient cellular material for diagnostic evaluation [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/34\">",
"     34",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=see_link&amp;anchor=H5#H5\">",
"     \"Evaluation of bone marrow aspirate smears\", section on 'The dry tap'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    There have been rare reports of unexplained iliac crest bone marrow hypoplasia, not explained by sampling issues or by previous trauma or radiation to the site [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h2\">",
"     Tests to be performed",
"    </span>",
"    &nbsp;&mdash;&nbsp;The tests which are ordered with a bone marrow aspiration and biopsy are dependent on the clinical scenario and the diagnoses that are being entertained (",
"    <a class=\"graphic graphic_table graphicRef82481 \" href=\"UTD.htm?26/52/27467\">",
"     table 2",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     TECHNIQUE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h2\">",
"     Materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;The supplies necessary for a bone marrow biopsy and aspiration, with the exception of sterile gloves and vials for specific studies on the collected samples, are conventionally packaged in a single tray. The contents should include all of the following:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Povidone-iodine antiseptic solution for cleansing the chosen site, along with the necessary drapes to maintain sterility at the site",
"     </li>",
"     <li>",
"      A 1 or 2 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      solution for local anesthesia, along with a sterile syringe, a 23-gauge and a 21-gauge needle",
"     </li>",
"     <li>",
"      A number 11 scalpel blade for making the skin incision prior to inserting the aspiration and biopsy needles",
"     </li>",
"     <li>",
"      Sufficient quantities of sterile gauze and bandages to clean the biopsy site and to apply local pressure to insure hemostasis when the procedure has been completed",
"     </li>",
"     <li>",
"      A large selection of needles used for aspiration is available. A needle with a stylet that can be fixed in place initially and removed later is preferred. It is important to use a sharp needle, as well as one long enough to penetrate through the subcutaneous tissues and into the marrow cavity. A needle chosen for sternal aspiration should be shorter than one used for aspiration at the iliac crest, and should be equipped with a guard to insure controlled entrance into (and not beyond) the sternal marrow cavity (see",
"      <a class=\"local\" href=\"#H19\">",
"       'Sternal aspiration'",
"      </a>",
"      below).",
"     </li>",
"     <li>",
"      Jamshidi biopsy needle with stylet and a device (obturator) for removing the biopsy core from the needle without damage to the specimen.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h2\">",
"     Posterior iliac crest",
"    </span>",
"    &nbsp;&mdash;&nbsp;Proper bone marrow aspiration and biopsy requires strict attention to detail. The following items should be completed in the order in which they appear:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Administer any necessary premedications (anti-anxiolytics or pain medications) (see",
"      <a class=\"local\" href=\"#H8\">",
"       'Premedications'",
"      </a>",
"      above).",
"     </li>",
"     <li>",
"      The patient should be placed in either a prone or lateral decubitus position. In heavier patients, a lateral decubitus position with the knees pulled closer to the chest, or a prone position accompanied by pressure over the bone, may help to identify the landmarks by reducing the depth of the fat pad overlying the iliac crest [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/36\">",
"       36",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Examine the potential site for evidence of infection; palpate the posterior iliac crest and posterior superior iliac spine and locate these landmarks (",
"      <a class=\"graphic graphic_figure graphicRef78950 \" href=\"UTD.htm?15/51/16177\">",
"       figure 1",
"      </a>",
"      ). The anterior superior iliac spine should also be palpated and located, as the needle will be pointed in this direction once the bone has been entered (",
"      <a class=\"graphic graphic_figure graphicRef51068 \" href=\"UTD.htm?16/62/17382\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Maintain a steady dialogue with the patient, explaining each step, alerting the patient to potential discomfort, with reassurance as needed.",
"     </li>",
"     <li>",
"      In the absence of local skin problems (eg, infection, induration, ulceration), the usual site for aspiration and biopsy is approximately three finger-widths from the midline and two finger-widths inferior to the iliac crest. Mark the chosen area by making an indentation in the skin with a coin, fingernail, or the end of a ballpoint pen with the writing tip retracted.",
"     </li>",
"     <li>",
"      Using sterile technique, protective clothing and gloves (and eye wear if necessary), the bone marrow tray should be first opened and organized for easy access to needed items. Needles, stylets, and plastic (not glass) syringes should be checked to ensure that they are intact and function properly.",
"     </li>",
"     <li>",
"      Cleanse the chosen area with povidone-iodine solution and drape a sterile field. Prepare the instruments.",
"     </li>",
"     <li>",
"      Anesthetize the skin and subcutaneous tissues with a 1 to 2 percent",
"      <a class=\"drug drug_general\" href=\"UTD.htm?34/34/35360?source=see_link\">",
"       lidocaine",
"      </a>",
"      solution (",
"      <a class=\"graphic graphic_table graphicRef74256 \" href=\"UTD.htm?30/54/31597\">",
"       table 3",
"      </a>",
"      ) using a 23-gauge needle; then anesthetize the periosteum by repeatedly injecting small amounts of lidocaine solution at different points on the surface of the bone with a 21-gauge needle. It is useful to anesthetize a dime-sized area of the periosteum surrounding the targeted location, as the aspiration and biopsy should be taken from slightly different adjacent sites.",
"     </li>",
"     <li>",
"      While waiting for the anesthetic to produce its effect, extra syringes for special studies (eg, flow cytometry, cytogenetics, and molecular studies) can be appropriately anticoagulated. Specimens for molecular studies should not contain",
"      <a class=\"drug drug_general\" href=\"UTD.htm?39/34/40489?source=see_link\">",
"       heparin",
"      </a>",
"      . The help of an assistant is invaluable.",
"     </li>",
"     <li>",
"      Once local anesthesia has been achieved, make a small (three mm) skin incision with a scalpel blade at the site of insertion of the aspiration needle, in order to facilitate its entry and promote organized healing of the wound.",
"     </li>",
"     <li>",
"      Hold the bone marrow needle (with stylet in place) perpendicular to the skin at the previously marked point, and gently advance it to the periosteum. In order to be sure that the needle is entering correctly, the second and third fingers on the hand not being used to insert the needle should be placed on the iliac crest or spine and the needle inserted between them [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3\">",
"       3",
"      </a>",
"      ]. When the needle has been advanced to the periosteum, it should be pointed in the direction of the anterior superior iliac spine (",
"      <a class=\"graphic graphic_figure graphicRef51068 \" href=\"UTD.htm?16/62/17382\">",
"       figure 2",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      Use a steady twisting back and forth motion. Do not twist more than 180 degrees to penetrate the periosteum and the cortical bone; a \"give\" is felt when the needle enters the marrow cavity. At the point of entry, the patient may express complaints of a deep-seated pain. It is important to alert the patient to this possibility ahead of time. Continue to advance the needle slightly to ensure that it is anchored into the bone.",
"     </li>",
"     <li>",
"      Remove the stylet, attach a two mL syringe to the aspiration needle, and again advise the patient that the aspiration may cause a brief period of pain.",
"     </li>",
"     <li>",
"      Aspirate 0.2 to 0.5 mL of marrow contents and remove the syringe. It may be necessary to attach additional syringes if many studies have been ordered. In general it is prudent to avoid aspirating more than 0.5 mL per syringe, as greater amounts may be prone to contamination with peripheral blood or to clotting [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The nonanticoagulated specimen should be handed to the assistant, who will assess the quality of the sample (ie, determine the presence or absence of grossly visible bone spicules) and prepare the various smears. Anticoagulated specimens should be sent to the laboratory for further preparation and other tests (eg, cytogenetics, molecular studies, cultures, flow cytometry). The patient should be made aware of the need for multiple specimens at the outset, since each separate aspiration may be painful, despite fully adequate local anesthesia.",
"     </li>",
"     <li>",
"      If aspiration attempts are not successful, reinsert the stylet (the needle may be rotated) and advance the needle a short distance; repeat attempts at aspiration with the syringe and suction. If multiple aspiration attempts are unsuccessful, an alternate site (eg, the other posterior iliac crest) may be approached with the same sterile strategy after the bone marrow biopsy has been obtained.",
"     </li>",
"     <li>",
"      Once it has been determined that the aspirate is satisfactory, reinsert the stylet, and remove the needle (with stylet in place) by using a similar twisting motion, and apply pressure to the site with a small gauze square until the bleeding stops.",
"     </li>",
"     <li>",
"      If a biopsy is necessary, prepare the Jamshidi needle and advance it into the cortical bone, using the same incision but a slightly different site, with a steady twisting movement until it is firmly lodged. This may require a greater amount of pressure than was used for the aspiration. Remove the stylet and with a rotating motion advance the needle another 15 to 20 mm.",
"     </li>",
"     <li>",
"      Redirect the needle tip and rotate it 360 degrees in both directions to separate the biopsy specimen from the surrounding marrow tissue. Following this step, the needle should be advanced a very short distance prior to removal. This step may prevent the specimen from being pulled out of the needle at the biopsy site.",
"     </li>",
"     <li>",
"      Remove the needle with a slight twisting motion, place a sterile dressing over the site, and apply pressure for several minutes until the bleeding stops. Once hemostasis is achieved, a bandage should be applied, and the patient should be instructed to lie supine for 10 or more minutes. Pressure dressings may be required in thrombocytopenic patients.",
"     </li>",
"     <li>",
"      Once the biopsy needle has been removed, the specimen may be extracted from the needle by inserting the obturator (or stylet) through the distal (cutting) end of the needle. The bone marrow biopsy can then be placed on a slide, where imprints (\"touch prints\") are made before the core specimen is further processed for cytologic investigations. This step is especially useful in situations where a bone marrow aspirate could not be obtained (see",
"      <a class=\"local\" href=\"#H13\">",
"       'The dry tap'",
"      </a>",
"      above)&nbsp;[",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3\">",
"       3",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Examine the biopsy specimen. If the specimen consists mostly of homogeneous, white material (cortical bone) or glistening tissue (cartilage), it may be necessary to attempt a second biopsy for a more satisfactory specimen. This should be done with a new biopsy needle, as the original needle may have been damaged by the process of inserting the obturator or stylet through the distal end of the biopsy needle.",
"     </li>",
"     <li>",
"      Prior to leaving the patient, the bone marrow",
"      <span class=\"nowrap\">",
"       aspiration/biopsy",
"      </span>",
"      site(s) should be evaluated to assess for prolonged bleeding. This is minimized by applying a pressure dressing over the site(s), with the patient remaining recumbent, for at least 10 minutes.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H18\">",
"    <span class=\"h2\">",
"     Anterior iliac crest",
"    </span>",
"    &nbsp;&mdash;&nbsp;Samples are taken from a site 2.5 to 5 cm posterior the anterior superior iliac spine and beneath the palpable lip of the iliac crest (",
"    <a class=\"graphic graphic_figure graphicRef51068 \" href=\"UTD.htm?16/62/17382\">",
"     figure 2",
"    </a>",
"    ) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient should be relaxed, comfortable, and in the supine position.",
"     </li>",
"     <li>",
"      Once a satisfactory site has been identified, the remainder of the procedure is identical to that for the posterior iliac crest (see above).",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19\">",
"    <span class=\"h2\">",
"     Sternal aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;This procedure should only be undertaken in patients more than 12 years old. Select a level of the sternum at either the second or third intercostal space (",
"    <a class=\"graphic graphic_figure graphicRef53887 \" href=\"UTD.htm?35/21/36183\">",
"     figure 3",
"    </a>",
"    )&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/10\">",
"     10",
"    </a>",
"    ]. Aspiration should be attempted only from the first part of the body of the sternum, or from the manubrium [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/4\">",
"     4",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The patient should be positioned in a semi-recumbent or supine position",
"     </li>",
"     <li>",
"      Ensure that the aspiration needle functions properly and that the guard is",
"      <strong>",
"       securely",
"      </strong>",
"      in place. The guard should be adjusted so that only 5 mm advancement of the needle is possible beyond the periosteum [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/38\">",
"       38",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Insert the needle slightly to one side of the midline at 90 degrees to the surface of the bone, as bone marrow tends to be less cellular at the midline (",
"      <a class=\"graphic graphic_figure graphicRef53887 \" href=\"UTD.htm?35/21/36183\">",
"       figure 3",
"      </a>",
"      ).",
"     </li>",
"     <li>",
"      The remainder of the sternal aspiration technique is similar to that used for the iliac crest. As noted above, a biopsy at this site is",
"      <strong>",
"       contraindicated.",
"      </strong>",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H20\">",
"    <span class=\"h2\">",
"     Tibial aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Tibial aspiration should be undertaken only in children less than 12 to 18 months old [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The site of aspiration should be in the upper third of the bone and slightly medial to the anterior crest, from the flat triangular area at the proximal end of the medial surface of the tibia, just below the tibial tubercle [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/37\">",
"       37",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Angle the needle posterolaterally. Once the needle is secured into the bone, aspiration should be attempted, since the \"give\" typically felt on aspiration of marrow from the iliac crest is characteristically absent at this site.",
"     </li>",
"     <li>",
"      Remove the stylet. Attach a 10 mL syringe and pull back the barrel with some force in order to aspirate sufficient material from the marrow cavity [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/10\">",
"       10",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H21\">",
"    <span class=\"h2\">",
"     Surgical biopsy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow examination may be obtained by an incisional biopsy at a number of different bony sites. An appropriate site is usually determined by prior examination of the patient or by the appropriate radiologic method (eg, CT scan, MRI). As an example, when investigating a patient with possible metastatic cancer or multiple myeloma, it is important to choose an area where there is clinical or radiologic evidence for potential bone marrow invasion [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3\">",
"     3",
"    </a>",
"    ]. Such procedures may be performed under CT guidance, as required. Bone marrow may also be obtained at the time of a related surgical procedure (eg, resection of a deep lymph node, splenectomy).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H22\">",
"    <span class=\"h1\">",
"     PREPARATION OF SAMPLES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Slides of the aspirated marrow may be prepared at the bedside, or the aspirated material may be anticoagulated and smeared at a later time. Depending on the clinical scenario, up to nine bone marrow direct smears may be prepared.",
"   </p>",
"   <p>",
"    When performed at the bedside, slides should be prepared rapidly to avoid clotting. Adequacy of the specimen is determined by the presence of \"spicules,\" which appear as fatty droplets, granules, or small chunks of bone, which allow assessment of marrow cellularity. Spicules tend to concentrate at the feathered edge when a smear of the bone marrow is made.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H23\">",
"    <span class=\"h2\">",
"     Materials",
"    </span>",
"    &nbsp;&mdash;&nbsp;The necessary materials for preparation of aspirate smears include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Glass slides and coverslips. Both should be clean and free of dirt, grease, oil, or fingerprints",
"     </li>",
"     <li>",
"      Sample collection tube(s) with EDTA (liquid EDTA for best morphology)",
"     </li>",
"     <li>",
"      Heparinized tubes with culture medium for special studies",
"     </li>",
"     <li>",
"      Pusher device for making slides (forceps with hemacytometer cover glass)",
"     </li>",
"     <li>",
"      Petri dish and Pasteur pipette (for coverslip preparations)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H24\">",
"    <span class=\"h2\">",
"     Procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Place the glass slides in a convenient location before the procedure to allow quick and easy access. Place approximately 0.5 mL of marrow aspirate on one glass slide; if only one or two aspirate samples are to be prepared, the remainder may be added to an EDTA-anticoagulated sample collection tube, mixing well. This should be done immediately to prevent clotting of the specimen. Preparations are then made using one or more of the following three techniques:",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H25\">",
"    <span class=\"h3\">",
"     Wedge technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;A few \"particles\" (spicules) are placed at the end of one slide and spread evenly down the length using a second glass slide [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/2\">",
"     2",
"    </a>",
"    ]. The second slide should be angled at 30 degrees to the base slide; the drop should be pushed using a rapid, even motion, ending in a particle (spicule)-rich feathered edge [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3,39\">",
"     3,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H26\">",
"    <span class=\"h3\">",
"     Particle crush technique",
"    </span>",
"    &nbsp;&mdash;&nbsp;This technique yields superior samples than does the wedge technique, but also requires more experience. With this technique, hematopoietic cells are more concentrated and mast cells are more easily evaluated.",
"   </p>",
"   <p>",
"    As in the wedge technique, a small drop of aspirated marrow is placed at the end of a glass slide. A second glass slide is held parallel and directly over the drop of the aspirate. The second slide is then pressed against the drop of aspirate and pulled across the full length of the first slide to crush open and spread the marrow particles [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3,39\">",
"     3,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H27\">",
"    <span class=\"h3\">",
"     Coverslip preparations",
"    </span>",
"    &nbsp;&mdash;&nbsp;This type of preparation is considered the most complex of the three types, but yields superior morphology when compared with the wedge or particle crush methods:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      1 to 2 mL of aspirate from the first draw is placed into a petri dish; the dish is then tilted at a slight angle to drain off the blood, making the marrow particles (spicules) more visible.",
"     </li>",
"     <li>",
"      One or two particles are then aspirated into a Pasteur pipette and placed on a 22 X 22 mm cover slip.",
"     </li>",
"     <li>",
"      A second cover slip is placed diagonally over the first; slight pressure is applied, crushing the particles gently.",
"     </li>",
"     <li>",
"      The two cover slips are pulled apart to produce smears. They are then placed into another clean, labeled Petri dish to await staining [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3,39\">",
"       3,39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H28\">",
"    <span class=\"h2\">",
"     Particle \"clot\" section",
"    </span>",
"    &nbsp;&mdash;&nbsp;This type of specimen is composed of histologic sections of aspirated material.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The simplest preparation requires drawing a small amount of aspirated material into a plain syringe and allowing it to clot spontaneously; a small amount of thrombin solution may be added to expedite this procedure.",
"     </li>",
"     <li>",
"      Another type of preparation, which allows better visualization of the aspirate particles, requires placing a small amount of aspirate into a collection tube containing EDTA. In the laboratory, the anticoagulated material is poured into a bag, where particles are trapped and excess blood is allowed to filter through. The particles are fixed and submitted for processing, sectioning, and staining. The filtered blood is concentrated into four layers by centrifugation; each layer may then be prepared into individual smears [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3,39\">",
"       3,39",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H29\">",
"    <span class=\"h2\">",
"     Biopsy imprint (\"touch\") preparation",
"    </span>",
"    &nbsp;&mdash;&nbsp;If the aspirated specimen is inadequate (devoid of particles) or unobtainable (dry tap), a touch preparation may be prepared from the biopsy core. Cells on the surface of the biopsy core stick to slides and are stained for morphologic, cytochemical, or immunoperoxidase evaluation.",
"   </p>",
"   <p>",
"    This technique requires placing a fresh core biopsy specimen onto a clean microscope slide. A second slide is then pressed against the core specimen and rolled slightly from side to side. Two or three slides with several imprints on each slide should be prepared in this manner [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/3,39\">",
"     3,39",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H30\">",
"    <span class=\"h1\">",
"     POST-PROCEDURE INSTRUCTIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Following the procedure, the patient should lie in a supine position, so as to apply body weight to the biopsy site, for at least 10 to 15 minutes. The site should then be inspected to ensure that there is no further bleeding. The patient should be advised that the procedure site may be slightly tender for several days. The following additional routine instructions should be given:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      For pain control, a dose of",
"      <a class=\"drug drug_general\" href=\"UTD.htm?15/27/15802?source=see_link\">",
"       acetaminophen",
"      </a>",
"      650 mg orally is usually adequate. If necessary, the patient may be instructed to continue acetaminophen 650 mg every 4 to 6 hours as necessary for the subsequent 24 to 48-hour period.",
"     </li>",
"     <li>",
"      The patient should be directed to contact the physician or clinic if swelling, marked tenderness, increased pain,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      further bleeding is observed [",
"      <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/39\">",
"       39",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      The patient should avoid overexertion (eg, heavy activity or exercise) for at least 24 hours, to avoid potential pain or bleeding at the site of the procedure. The area of the",
"      <span class=\"nowrap\">",
"       aspiration/biopsy",
"      </span>",
"      should be kept dry, using a small dressing or bandage, during this time to minimize the chance of infection or bleeding.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    If the patient continues to bleed from the",
"    <span class=\"nowrap\">",
"     aspirate/biopsy",
"    </span>",
"    site after an initial observation period of 10 to 15 minutes, it may be prudent to reapply pressure to the site and have the patient lie supine for at least one hour. If bleeding continues after this additional time of observation, it may be necessary to transfuse platelets if the patient is severely thrombocytopenic or if platelet function is suspected to be compromised.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H31\">",
"    <span class=\"h1\">",
"     COMPLICATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications following bone marrow biopsy are rare. In a survey of members of the British Society of Haematology reported in 2003, there were 26 adverse events, including one fatality, out of an estimated total of 55,000 biopsy procedures (0.05 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/40\">",
"     40",
"    </a>",
"    ]. A follow-up survey of this group, reported in 2006 involving 20,323 procedures, resulted in the reporting of 15 adverse events (0.07 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Risk factors for an adverse event included diagnosis of a myeloproliferative disorder, treatment with",
"    <a class=\"drug drug_general\" href=\"UTD.htm?24/7/24698?source=see_link\">",
"     aspirin",
"    </a>",
"    or",
"    <a class=\"drug drug_general\" href=\"UTD.htm?27/41/28314?source=see_link\">",
"     warfarin",
"    </a>",
"    , obesity, or disseminated intravascular coagulation. In general, however, when complications do occur, they tend to be minor, mainly consisting of bleeding at the",
"    <span class=\"nowrap\">",
"     biopsy/aspiration",
"    </span>",
"    site or infection (",
"    <a class=\"graphic graphic_table graphicRef58801 \" href=\"UTD.htm?6/30/6635\">",
"     table 4",
"    </a>",
"    ).",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H32\">",
"    <span class=\"h2\">",
"     Bleeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;Hemorrhage from bone marrow aspiration can occur at any site, is more likely in the individual with thrombocytopenia",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    abnormal platelet function, and is associated most commonly with the myeloproliferative disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/40-43\">",
"     40-43",
"    </a>",
"    ]. Of interest, the risk of hemorrhage has not been found to be associated with operator experience [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/41\">",
"     41",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most cases, bleeding is controlled by manual application of pressure to the site. Pressure dressings should be applied to the site following the procedure in patients with thrombocytopenia. If bleeding continues, platelet transfusions may have to be given if the patient is severely thrombocytopenic, or if platelet function is compromised.",
"   </p>",
"   <p>",
"    There have been rare reports of retroperitoneal hemorrhage [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/10,44,45\">",
"     10,44,45",
"    </a>",
"    ], gluteal artery laceration or pseudoaneurysm with gluteal compartment syndrome [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/41,46\">",
"     41,46",
"    </a>",
"    ], and internal iliac artery pseudoaneurysm [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/45\">",
"     45",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H33\">",
"    <span class=\"h2\">",
"     Infection",
"    </span>",
"    &nbsp;&mdash;&nbsp;Infections are usually minor, requiring only topical medications. More serious infections may occur in immunocompromised patients. There is a potential risk of contracting infections from a patient, and some recommend double-gloving. However, universal precautions should be applied in all cases, and the operator should always take care to avoid needle penetration of the skin.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H34\">",
"    <span class=\"h2\">",
"     Tumor seeding",
"    </span>",
"    &nbsp;&mdash;&nbsp;There have been rare case reports of tumor seeding from the bone marrow into the needle track (eg, into muscle, subcutaneous tissue, skin) following bone marrow biopsy, in patients with small cell lung carcinoma, multiple myeloma, and lymphoma [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/47-49\">",
"     47-49",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H35\">",
"    <span class=\"h2\">",
"     Needle breakage",
"    </span>",
"    &nbsp;&mdash;&nbsp;Rarely, a bone marrow needle may break. If this occurs, an attempt to extract the distal segment with a hemostat should be made. If this maneuver is unsuccessful, a surgeon should be consulted.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H36\">",
"    <span class=\"h2\">",
"     Sternal aspiration",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of sternal aspiration are rare, but merit special consideration due to their potential seriousness. The sternum is only one centimeter thick in the adult, which may predispose to through-and-through penetration of the sternum with potentially fatal cardiovascular complications, pericardial tamponade, pneumothorax, pulmonary emboli, infection, and bone erosion, thinning, or sternal fracture [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/50\">",
"     50",
"    </a>",
"    ]. Sternal aspiration should not be undertaken in young children due to the risk of perforating the sternal plate. For the same reasons, marrow biopsy at sternal sites is contraindicated.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H37\">",
"    <span class=\"h2\">",
"     Other",
"    </span>",
"    &nbsp;&mdash;&nbsp;Seldom, patients may experience persistent discomfort at the site of biopsy [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/41\">",
"     41",
"    </a>",
"    ]. Exceedingly rare complications have included transient neuropathy with gluteal compartment syndrome secondary to post-biopsy bleeding [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/51\">",
"     51",
"    </a>",
"    ], fracture due to underlying osteoporosis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/41\">",
"     41",
"    </a>",
"    ], and osteomyelitis [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/2\">",
"     2",
"    </a>",
"    ]. There may be abnormal radiologic studies of the pelvis post-biopsy, including lytic lesions surrounded by a sclerotic border [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/52\">",
"     52",
"    </a>",
"    ], exostoses [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/53,54\">",
"     53,54",
"    </a>",
"    ], or increased bone-seeking isotope uptake [",
"    <a class=\"abstract\" href=\"UTD.htm?5/22/5482/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16991050\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16991058\">",
"    <span class=\"h2\">",
"     Indications and contraindications",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16991094\">",
"    <span class=\"h3\">",
"     Indications",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following medical settings constitute the major indications for bone marrow aspiration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biopsy. (See",
"    <a class=\"local\" href=\"#H3\">",
"     'Indications'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Evaluation of unexplained anemia, leukopenia, thrombocytopenia, or pancytopenia",
"     </li>",
"     <li>",
"      Diagnosis and staging of lymphoma or solid tumors",
"     </li>",
"     <li>",
"      Evaluation of elevated peripheral blood counts (eg, polycythemia, thrombocytosis, leukocytosis)",
"     </li>",
"     <li>",
"      Diagnosis and evaluation of plasma cell disorders and leukemias",
"     </li>",
"     <li>",
"      Evaluation of iron metabolism and iron stores",
"     </li>",
"     <li>",
"      Evaluation of suspected deposition and storage diseases (eg, amyloidosis, Gaucher disease)",
"     </li>",
"     <li>",
"      Evaluation of fever of undetermined origin, suspected mycobacterial, fungal, or parasitic infections, or granulomatous diseases",
"     </li>",
"     <li>",
"      Unexplained splenomegaly",
"     </li>",
"     <li>",
"      Evaluation of suspected chromosomal disorders in neonates",
"     </li>",
"     <li>",
"      Confirmation that the bone marrow is normal in a potential allogeneic hematopoietic cell donor",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16991101\">",
"    <span class=\"h3\">",
"     Contraindications",
"    </span>",
"    &nbsp;&mdash;&nbsp;Bone marrow aspiration",
"    <span class=\"nowrap\">",
"     and/or",
"    </span>",
"    biopsy is contraindicated in the following settings. (See",
"    <a class=\"local\" href=\"#H4\">",
"     'Contraindications'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Hemophilia",
"     </li>",
"     <li>",
"      Severe disseminated intravascular coagulopathy, or other related severe bleeding disorders.",
"     </li>",
"     <li>",
"      Thrombocytopenia, regardless of severity, is",
"      <strong>",
"       not",
"      </strong>",
"      a contraindication",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16991124\">",
"    <span class=\"h2\">",
"     Aspiration/biopsy sites",
"    </span>",
"    &nbsp;&mdash;&nbsp;The following anatomical sites can be used for bone marrow aspiration. (See",
"    <a class=\"local\" href=\"#H6\">",
"     'Choice of aspiration or biopsy site'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Posterior (preferred) or anterior iliac crest. The iliac crest is the only site at which both aspiration and biopsy may be safely performed in the adult.",
"     </li>",
"     <li>",
"      Sternum. Marrow may be aspirated from the sternum by experienced clinicians; biopsy at this site is",
"      <strong>",
"       contraindicated.",
"      </strong>",
"     </li>",
"     <li>",
"      Other sites include the tibia, femur, vertebral bodies, ribs. Surgical consultation is advisable when such sites are considered, especially for open biopsies",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16991147\">",
"    <span class=\"h2\">",
"     Complications of the procedure",
"    </span>",
"    &nbsp;&mdash;&nbsp;Complications of bone marrow",
"    <span class=\"nowrap\">",
"     aspiration/biopsy",
"    </span>",
"    are uncommon (estimated at 0.05 to 0.07 percent in two series). (See",
"    <a class=\"local\" href=\"#H31\">",
"     'Complications'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      The most commonly encountered complications include pain, discomfort,",
"      <span class=\"nowrap\">",
"       and/or",
"      </span>",
"      bleeding at the site of the procedure.",
"     </li>",
"     <li>",
"      Complications of sternal aspiration can be serious and are discussed in detail above. (See",
"      <a class=\"local\" href=\"#H36\">",
"       'Sternal aspiration'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/1\">",
"      Malempati S, Joshi S, Lai S, et al. Videos in clinical medicine. Bone marrow aspiration and biopsy. N Engl J Med 2009; 361:e28.",
"     </a>",
"    </li>",
"    <li>",
"     Foucar K. Bone Marrow Pathology, 2nd ed, ASCP Press, Chicago 2001.",
"    </li>",
"    <li>",
"     Ryan DH, Cohen HJ. Bone marrow aspiration and morphology. In: Hematology: Basic Principles and Practice, 3rd ed, Hoffman R, Benz EJ, Shattil SJ, et al. (Eds), Churchill Livingstone, Philadelphia 2000. p.2460.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/4\">",
"      Bain BJ. Bone marrow aspiration. J Clin Pathol 2001; 54:657.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/5\">",
"      Subramanian R, Basu D, Badhe B, Dutta TK. Role of bone marrow trephine biopsy in the diagnosis of marrow involvement in Hodgkin's disease. Indian J Pathol Microbiol 2007; 50:640.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/6\">",
"      Ozkalemkas F, Ali R, Ozkocaman V, et al. The bone marrow aspirate and biopsy in the diagnosis of unsuspected nonhematologic malignancy: a clinical study of 19 cases. BMC Cancer 2005; 5:144.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/7\">",
"      Moid F, DePalma L. Comparison of relative value of bone marrow aspirates and bone marrow trephine biopsies in the diagnosis of solid tumor metastasis and Hodgkin lymphoma: institutional experience and literature review. Arch Pathol Lab Med 2005; 129:497.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/8\">",
"      Subramanian R, Basu D, Dutta TK. Significance of bone marrow fibrosis in multiple myeloma. Pathology 2007; 39:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/9\">",
"      Ahmad Z, Durrani NU, Hazir T. Bone marrow examination in ITP in children: is it mandatory ? J Coll Physicians Surg Pak 2007; 17:347.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/10\">",
"      Hyun BH, Gulati GL, Ashton JK. Bone marrow examination: techniques and interpretation. Hematol Oncol Clin North Am 1988; 2:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/11\">",
"      ELLIS LD, JENSEN WN, WESTERMAN MP. NEEDLE BIOPSY OF BONE AND MARROW; AN EXPERIENCE WITH 1,445 BIOPSIES. Arch Intern Med 1964; 114:213.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/12\">",
"      Rebulla P. Platelet transfusion trigger in difficult patients. Transfus Clin Biol 2001; 8:249.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/13\">",
"      Eikelboom JW. Bone marrow biopsy in thrombocytopenic or anticoagulated patients. Br J Haematol 2005; 129:562.",
"     </a>",
"    </li>",
"    <li>",
"     Johns Hopkins: The Harriet Lane Handbook: A Manual for Pediatric House Officers, 16th ed, Mosby, 2002.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/15\">",
"      Devaliaf V, Tudor G. Bone marrow examination in obese patients. Br J Haematol 2004; 125:538.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/16\">",
"      Talamo G, Liao J, Joudeh J, et al. Perceived levels of pain associated with bone marrow aspirates and biopsies. J Support Oncol 2012; 10:166.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/17\">",
"      von Gunten CF, Soskins M. Bone marrow biopsy symptom control and palliative care consultation. J Pain Symptom Manage 2007; 33:236.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/18\">",
"      Talamo G, Liao J, Bayerl MG, et al. Oral administration of analgesia and anxiolysis for pain associated with bone marrow biopsy. Support Care Cancer 2010; 18:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/19\">",
"      Henry DW, Burwinkle JW, Klutman NE. Determination of sedative and amnestic doses of lorazepam in children. Clin Pharm 1991; 10:625.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/20\">",
"      Burkle CM, Harrison BA, Koenig LF, et al. Morbidity and mortality of deep sedation in outpatient bone marrow biopsy. Am J Hematol 2004; 77:250.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/21\">",
"      Dunlop TJ, Deen C, Lind S, et al. Use of combined oral narcotic and benzodiazepine for control of pain associated with bone marrow examination. South Med J 1999; 92:477.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/22\">",
"      Milligan DW, Howard MR, Judd A. Premedication with lorazepam before bone marrow biopsy. J Clin Pathol 1987; 40:696.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/23\">",
"      Vanhelleputte P, Nijs K, Delforge M, et al. Pain during bone marrow aspiration: prevalence and prevention. J Pain Symptom Manage 2003; 26:860.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/24\">",
"      Gudgin EJ, Besser MW, Craig JI. Entonox as a sedative for bone marrow aspiration and biopsy. Int J Lab Hematol 2008; 30:65.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/25\">",
"      Steedman B, Watson J, Ali S, et al. Inhaled nitrous oxide (Entonox) as a short acting sedative during bone marrow examination. Clin Lab Haematol 2006; 28:321.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/26\">",
"      Parapia LA. Trepanning or trephines: a history of bone marrow biopsy. Br J Haematol 2007; 139:14.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/27\">",
"      Douglas DD, Risdall RJ. Bone marrow biopsy technic. Artifact induced by aspiration. Am J Clin Pathol 1984; 82:92.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/28\">",
"      Brynes RK, McKenna RW, Sundberg RD. Bone marrow aspiration and trephine biopsy. An approach to a thorough study. Am J Clin Pathol 1978; 70:753.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/29\">",
"      Brunning RD, Bloomfield CD, McKenna RW, Peterson LA. Bilateral trephine bone marrow biopsies in lymphoma and other neoplastic diseases. Ann Intern Med 1975; 82:365.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/30\">",
"      Menon NC, Buchanan JG. Bilateral trephine bone marrow biopsies in Hodgkin's and non-Hodgkin's lymphoma. Pathology 1979; 11:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/31\">",
"      Juneja SK, Wolf MM, Cooper IA. Value of bilateral bone marrow biopsy specimens in non-Hodgkin's lymphoma. J Clin Pathol 1990; 43:630.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/32\">",
"      George TB, Natkunam FL, Geaghan Y, et al. Bone marrow biopsy for focal disease detection: evaluation of optimal biopsy length and comparison of bilateral to equivalent-length unilateral biopsies. Mod Pathol 2004; 17:248a.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/33\">",
"      Campbell JK, Matthews JP, Seymour JF, et al. Optimum trephine length in the assessment of bone marrow involvement in patients with diffuse large cell lymphoma. Ann Oncol 2003; 14:273.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/34\">",
"      Hazarika B. Touch imprint matters. Blood 2013; 121:2585.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/35\">",
"      Ferrant A, Rodhain J, Cordier A, et al. Selective hypoplasia of pelvic bone marrow. Scand J Haematol 1980; 25:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/36\">",
"      Ghosh K. Bone marrow examination in obese patients: CAT or not to CAT! Br J Haematol 2004; 127:230.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/37\">",
"      Knowles S, Hoffbrand AV. Bone-marrow aspiration and trephine biopsy (1). Br Med J 1980; 281:204.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/38\">",
"      Knowles S, Hoffbrand AV. Bone-marrow aspiration and trephine biopsy (2). Br Med J 1980; 281:280.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/39\">",
"      Riley RS, Hogan TF, Pavot DR, et al. A pathologist's perspective on bone marrow aspiration and biopsy: I. Performing a bone marrow examination. J Clin Lab Anal 2004; 18:70.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/40\">",
"      Bain BJ. Bone marrow biopsy morbidity and mortality. Br J Haematol 2003; 121:949.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/41\">",
"      Bain BJ. Morbidity associated with bone marrow aspiration and trephine biopsy - a review of UK data for 2004. Haematologica 2006; 91:1293.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/42\">",
"      Salem P, Wolverson MK, Reimers HJ, Kudva GC. Complications of bone marrow biopsy. Br J Haematol 2003; 121:821.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/43\">",
"      Le Dieu R, Luckit J, Sundarasun M. Complications of trephine biopsy. Br J Haematol 2003; 121:822.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/44\">",
"      Pedersen LM, Jarner D, Winge J. Bone-marrow biopsy of the iliac bone followed by severe retroperitoneal hemorrhage. Eur J Haematol 1993; 51:52.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/45\">",
"      Bailey MA, Farquharson NR, Coughlin PA, et al. Internal iliac artery pseudoaneurysm in an infant following bone marrow trephine biopsy. Br J Haematol 2011; 153:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/46\">",
"      Sullivan CM, Regi JM. Pseudoaneurysm of the superior gluteal artery following bone marrow biopsy. Br J Haematol 2013; 161:289.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/47\">",
"      Citron ML, Krasnow SH, Grant C, Cohen MH. Tumor seeding associated with bone marrow aspiration and biopsy. Arch Intern Med 1984; 144:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/48\">",
"      Kansara G, Hussain M, Dimauro J. A case of plasmacytoma in muscle as a complication of needle tract seeding after percutaneous bone marrow biopsy. Am J Clin Pathol 1989; 91:604.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/49\">",
"      Ginaldi S, Williams CD. Seeding of malignant lymphoma along the tract after bone marrow biopsy. South Med J 1985; 78:1007.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/50\">",
"      van Marum RJ, te Velde L. Cardiac tamponade following sternal puncture in two patients. Neth J Med 2001; 59:39.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/51\">",
"      Roth JS, Newman EC. Gluteal compartment syndrome and sciatica after bone marrow biopsy: a case report and review of the literature. Am Surg 2002; 68:791.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/52\">",
"      Gilsanz V, Grunebaum M. Radiographic appearance of lliac marrow biopsy sites. AJR Am J Roentgenol 1977; 128:597.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/53\">",
"      Murphy WA. Exostosis after iliac bone marrow biopsy. AJR Am J Roentgenol 1977; 129:1114.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/54\">",
"      Singer J, Cole J, Vas W. Bone marrow biopsy changes in the iliac bone mimicking multiple colonic polypi. Australas Radiol 1990; 34:262.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?5/22/5482/abstract/55\">",
"      Roman MR, Angelides S. Extrarenal uptake of 99mTc-DTPA at the site of bone marrow biopsy. Ann Nucl Med 2002; 16:143.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4436 Version 10.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-125.39.66.147-EFB8DDA1F5-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5482=[""].join("\n");
var outline_f5_22_5482=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H16991050\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      BACKGROUND INFORMATION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      INDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      CONTRAINDICATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      ADVANCED PREPARATION",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      Choice of aspiration or biopsy site",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      - The extremely obese patient",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Premedications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      Use of an assistant",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Needle selection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Sequence of aspiration and biopsy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Adequacy of the biopsy specimen",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      The dry tap",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      Tests to be performed",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      Materials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      Posterior iliac crest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H18\">",
"      Anterior iliac crest",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H19\">",
"      Sternal aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H20\">",
"      Tibial aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H21\">",
"      Surgical biopsy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H22\">",
"      PREPARATION OF SAMPLES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H23\">",
"      Materials",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H24\">",
"      Procedure",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H25\">",
"      - Wedge technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H26\">",
"      - Particle crush technique",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H27\">",
"      - Coverslip preparations",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H28\">",
"      Particle \"clot\" section",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H29\">",
"      Biopsy imprint (\"touch\") preparation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H30\">",
"      POST-PROCEDURE INSTRUCTIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H31\">",
"      COMPLICATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H32\">",
"      Bleeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H33\">",
"      Infection",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H34\">",
"      Tumor seeding",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H35\">",
"      Needle breakage",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H36\">",
"      Sternal aspiration",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H37\">",
"      Other",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16991050\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16991058\">",
"      Indications and contraindications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16991094\">",
"      - Indications",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H16991101\">",
"      - Contraindications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16991124\">",
"      Aspiration/biopsy sites",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H16991147\">",
"      Complications of the procedure",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"HEME/4436\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4436|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?27/2/27682\" title=\"diagnostic image 1\">",
"      Red marrow normal adult",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4436|FIG\">",
"      <a href=\"#\" title=\"FIGURES\">",
"       FIGURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?15/51/16177\" title=\"figure 1\">",
"      Posterior superior iliac spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?16/62/17382\" title=\"figure 2\">",
"      Ant superior iliac spine",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_figure\" href=\"UTD.htm?35/21/36183\" title=\"figure 3\">",
"      Sternal aspiration sites",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4436|PIC\">",
"      <a href=\"#\" title=\"PICTURES\">",
"       PICTURES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_picture\" href=\"UTD.htm?27/53/28500\" title=\"picture 1\">",
"      Normal bone marrow Low",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"HEME/4436|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?31/2/31787\" title=\"table 1\">",
"      Marrow asp bx indications",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?26/52/27467\" title=\"table 2\">",
"      Marrow asp bx available tests",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?30/54/31597\" title=\"table 3\">",
"      Local anesthetics",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?6/30/6635\" title=\"table 4\">",
"      Marrow asp bx complications",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?18/45/19161?source=related_link\">",
"      Approach to congenital malformations",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/46/29418?source=related_link\">",
"      Approach to the adult patient with anemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?33/34/34346?source=related_link\">",
"      Approach to the adult patient with splenomegaly and other splenic disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?15/19/15674?source=related_link\">",
"      Approach to the adult patient with thrombocytopenia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?31/11/31927?source=related_link\">",
"      Approach to the adult with fever of unknown origin",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/39/26234?source=related_link\">",
"      Causes and diagnosis of anemia due to iron deficiency",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/13/35034?source=related_link\">",
"      Clinical features, laboratory manifestations, and diagnosis of multiple myeloma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?30/13/30938?source=related_link\">",
"      Clinical manifestations and diagnosis of immune thrombocytopenia (ITP) in adults",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/58/20393?source=related_link\">",
"      Clinical manifestations, pathologic features, and diagnosis of acute myeloid leukemia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?26/61/27610?source=related_link\">",
"      Clinical presentation and diagnosis of non-Hodgkin lymphoma",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/38/26218?source=related_link\">",
"      Donor selection for hematopoietic cell transplantation",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?13/23/13689?source=related_link\">",
"      Evaluation of bone marrow aspirate smears",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/11/9402?source=related_link\">",
"      Gaucher disease: Pathogenesis, clinical manifestations, and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/2/24614?source=related_link\">",
"      Laboratory evaluation of neutropenia and neutrophil dysfunction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?24/34/25129?source=related_link\">",
"      Overview of hematopoiesis and stem cell function",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?41/35/42552?source=related_link\">",
"      Pathobiology and staging of small cell carcinoma of the lung",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?34/62/35815?source=related_link\">",
"      Pathogenesis of immunoglobulin light chain (AL) amyloidosis and light and heavy chain deposition diseases",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?42/23/43384?source=related_link\">",
"      Procedural sedation in children outside of the operating room",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?11/50/12073?source=related_link\">",
"      Remission criteria in acute myeloid leukemia and monitoring for residual disease",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f5_22_5483="Bilirubin albumin ratio BW";
var content_f5_22_5483=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F66898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F66898&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Bilirubin/albumin (mg/g) ratio as a criterion for exchange transfusion in preterm infants based upon birth weight",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Birth weight, g",
"       </td>",
"       <td class=\"subtitle1\">",
"        B/A range, mg/g (molar)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &lt;1250",
"       </td>",
"       <td>",
"        4.0-5.2 (0.30-0.42)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1250-1499",
"       </td>",
"       <td>",
"        5.2-6.0 (0.42-0.50)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1500-1999",
"       </td>",
"       <td>",
"        6.0-6.8 (0.50-0.58)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        2000-2499",
"       </td>",
"       <td>",
"        6.8-7.0 (0.78-0.80)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        &gt;2500",
"       </td>",
"       <td>",
"        &ge;7.0 (0.80)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     B/A: bilirubin/albumin ratio.",
"    </div>",
"    <div class=\"reference\">",
"     Data from: Ahlfors CE, Amin SB, Parker AE. Unbound bilirubin predicts abnormal automated auditory brainstem response in a diverse newborn population. J Perinatol 2009; 29:305.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5483=[""].join("\n");
var outline_f5_22_5483=null;
var title_f5_22_5484="Body weight in PD adequacy";
var content_f5_22_5484=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=NEPH%2F78283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=NEPH%2F78283&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Table showing the effect of body weight on Kt/V and creatinine clearance among peritoneal dialysis patients",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" colspan=\"4\">",
"        Body weight ratio, actual to desired",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        &nbsp;",
"       </td>",
"       <td class=\"subtitle2\">",
"        &lt;.09",
"       </td>",
"       <td class=\"subtitle2\">",
"        0.9-.11",
"       </td>",
"       <td class=\"subtitle2\">",
"        &gt;.11",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Percent of patients",
"       </td>",
"       <td class=\"centered\">",
"        19",
"       </td>",
"       <td class=\"centered\">",
"        33",
"       </td>",
"       <td class=\"centered\">",
"        48",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        BWa/BWd",
"       </td>",
"       <td class=\"centered\">",
"        0.82",
"       </td>",
"       <td class=\"centered\">",
"        1.01",
"       </td>",
"       <td class=\"centered\">",
"        1.37",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kt/Va",
"       </td>",
"       <td class=\"centered\">",
"        1.95",
"       </td>",
"       <td class=\"centered\">",
"        2.08",
"       </td>",
"       <td class=\"centered\">",
"        1.94",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Kt/Vd",
"       </td>",
"       <td class=\"centered\">",
"        1.74",
"       </td>",
"       <td class=\"centered\">",
"        2.08",
"       </td>",
"       <td class=\"centered\">",
"        2.25",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CCra, L/week",
"       </td>",
"       <td class=\"centered\">",
"        68.1",
"       </td>",
"       <td class=\"centered\">",
"        71.5",
"       </td>",
"       <td class=\"centered\">",
"        64.1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        CCrd, L/week",
"       </td>",
"       <td class=\"centered\">",
"        62.6",
"       </td>",
"       <td class=\"centered\">",
"        71.7",
"       </td>",
"       <td class=\"centered\">",
"        72.4",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    Effect of body weight, using actual (a) and desired (d) values, on Kt/V and weekly creatinine clearance (CCr). If the actual weight is used, patients well below the desired weight (ratio between actual and desired weight below 0.9) will overestimate solute clearance, while those well above the desired weight (ratio above 1.1) will underestimate solute clearance.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5484=[""].join("\n");
var outline_f5_22_5484=null;
var title_f5_22_5485="Ethics living donor transplant";
var content_f5_22_5485=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=GAST%2F65453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=GAST%2F65453&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    American Society of Transplant Surgeons Ethics Committee position paper on living donor liver transplantation",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Donor selection and evaluation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potential donors should be healthy individuals who are carefully",
"evaluated and approved by a multidisciplinary team, including",
"hepatologists and surgeons, to ensure that they can tolerate the",
"procedure",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potential donors should undergo evaluation to ensure that they fully understand the procedure and associated risks",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potential donors must be of legal age and have sufficient intellectual",
"ability to understand the procedure and give informed consent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potential donors who are believed or known to be coerced must be excluded",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Potential donors need to have the ability and willingness to comply with long-term follow-up",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Recipient criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recipients need to be medically suitable for liver transplantation by standard criteria of the transplant center",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Recipients need to understand and accept that the donation will put the donor at significant risk",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Although it may not be possible to firmly state",
"that adult-to-adult living donor liver transplantation should not be",
"performed in situations in which the recipient has a poor chance of",
"survival, the added risk to the donor must be balanced with a realistic",
"estimate of the chances of success.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Center criteria",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Centers should undergo careful institutional planning that shows the following:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Consideration of the significant risk of the procedure to the donor",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Establishment of an appropriate informed consent process",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Surgical expertise in liver transplantation and hepatobiliary surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        An",
"existing need for living donation versus cadaveric donation, shown by",
"insufficient cadaver organs for transplantation resulting in",
"potentially avoidable deaths on the waiting list",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Adequate resources, eg, multiple surgical teams, adequate operating room resources, and institutional support",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        Ongoing oversight",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Consent",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_single\">",
"        Informed consent for the procedure should contain the following elements:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The risk for death during or after the operation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The risk for liver failure resulting in the need for transplantation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The risk for life-threatening infection resulting from the operation",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The risk for blood-borne infection acquired through transfusion",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The risk for temporary or permanent disability",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\">",
"        The ability to withdraw from participation at any time before surgery",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\">",
"        Registry",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        The American Society of Transplant Surgeons",
"should implement a national registry for all living donor",
"liver transplant procedures",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     From: the American Society of Transplant Surgeons: Ethics Committee. Liver Transplant 2000; 6:815.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5485=[""].join("\n");
var outline_f5_22_5485=null;
var title_f5_22_5486="Comparison of selected hormonal contraceptives";
var content_f5_22_5486=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F80393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F80393&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Characteristics, effectiveness, advantages, side effects and risks of selected methods of contraception",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"6\" width=\"16%\">",
"     </colgroup>",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Method",
"       </td>",
"       <td class=\"subtitle1\">",
"        Characteristics",
"       </td>",
"       <td class=\"subtitle1\">",
"        Effectiveness",
"       </td>",
"       <td class=\"subtitle1\">",
"        Advantages",
"       </td>",
"       <td class=\"subtitle1\">",
"        Side effects and risks",
"       </td>",
"       <td class=\"subtitle1\">",
"        Comments",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Combined estrogen-progestin contraception",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"7\">",
"        Oral contraceptive pill",
"       </td>",
"       <td>",
"        Mechanism of action: inhibition of ovulation; endometrial effects; cervical mucus effects; tubal peristalsis",
"       </td>",
"       <td rowspan=\"7\">",
"        <p>",
"         Perfect use: 99.7 percent",
"        </p>",
"        <p>",
"         Typical use: 92 percent",
"        </p>",
"       </td>",
"       <td>",
"        Effective and reversible",
"       </td>",
"       <td>",
"        Side effects: irregular bleeding or spotting; breast tenderness; nausea; headache",
"       </td>",
"       <td rowspan=\"7\">",
"        <p>",
"         Not associated with weight gain",
"        </p>",
"        <p>",
"         Pill-free intervals not necessary",
"        </p>",
"        <p>",
"         No limit to duration of use in healthy women",
"        </p>",
"        <p>",
"         Final height of adolescent users not affected",
"        </p>",
"        <p>",
"         Future fertility not affected",
"        </p>",
"        <p>",
"         May be used by healthy, nonsmoking women over age 35",
"        </p>",
"        <p>",
"         Not teratogenic",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 pill daily: cyclically or continuously",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Noncontraceptive benefits:",
"       </td>",
"       <td class=\"sublist1_start\">",
"        Risks:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"5\">",
"        Initiation: first-day start (on first day of menses), Sunday start or \"quick start\" (at doctor's office)",
"       </td>",
"       <td class=\"sublist1\">",
"        - Cycle regulation; decreased menstrual flow; decreased dysmenorrhea",
"       </td>",
"       <td class=\"sublist1\">",
"        - Risk of venous thromboembolism: increased 3- to 4-fold; absolute risk is 1 to 1.5 events per 10,000 users per year of use; risk highest in first year of use",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Increased bone density",
"       </td>",
"       <td class=\"sublist1\">",
"        - No increased risk of myocardial infarction, cerebrovascular accident or gallbladder disease in healthy women",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Fewer perimenopausal symptoms",
"       </td>",
"       <td class=\"sublist1\" rowspan=\"3\">",
"        - Risk of breast cancer is increased only slightly if at all",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Less acne and hirsutism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"sublist1\">",
"        - Decreased risk of ovarian, endometrial and possibly colorectal cancer; fewer ovarian cysts; decreased incidence or severity of premenstrual symptoms",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"4\">",
"        Transdermal contraceptive patch",
"       </td>",
"       <td>",
"        Contains ethinyl estradiol and norelgestromin",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Perfect use: 99.7 percent",
"        </p>",
"        <p>",
"         Typical use: 92 percent",
"        </p>",
"       </td>",
"       <td>",
"        Effective and reversible",
"       </td>",
"       <td>",
"        Side effects: similar to those of oral contraceptives; local skin irritation in 20 percent",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         May be less effective in women weighing &gt;90 kg",
"        </p>",
"        <p>",
"         Higher overall estrogen dose, but lower peak levels, than with oral contraceptive",
"        </p>",
"        <p>",
"         Effect of avoiding first-pass metabolism in liver uncertain",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mechanism of action: same as that of oral contraceptive",
"       </td>",
"       <td>",
"        Once-a-week dosing schedule",
"       </td>",
"       <td>",
"        Patch detachment (uncommon)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        1 patch weekly: cyclically (1 patch weekly for 3 weeks, than 1 patch-free week) or continuously",
"       </td>",
"       <td>",
"        48-hour \"window of forgiveness\"",
"       </td>",
"       <td rowspan=\"2\">",
"        Risks: similar to those of oral contraceptive; possibly increased risk of venous thromboembolism",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Noncontraceptive benefits similar to those of oral contraceptive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"4\">",
"        Vaginal contraceptive ring",
"       </td>",
"       <td>",
"        Contains ethinyl estradiol and etonorgestrel",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Perfect use: 99.7 percent",
"        </p>",
"        <p>",
"         Typical use: 92 percent",
"        </p>",
"       </td>",
"       <td>",
"        Effective and reversible",
"       </td>",
"       <td>",
"        <p>",
"         Side effects: similar to those of oral contraceptive",
"        </p>",
"        <p>",
"         Ring-specific side effects: vaginitis (5.6 percent), leukorrhea (4.6 percent), vaginal discomfort (2.4 percent)",
"        </p>",
"       </td>",
"       <td rowspan=\"4\">",
"        <p>",
"         Vaginal spermicides and antifungals have no effect on ring efficacy",
"        </p>",
"        <p>",
"         Use does not worsen low-grade squamous intraepithelial lesions",
"        </p>",
"        <p>",
"         Effect of avoiding first-pass metabolism in liver uncertain",
"        </p>",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mechanism of action: same as that of oral contraceptive",
"       </td>",
"       <td>",
"        Once-a-month dosing schedule",
"       </td>",
"       <td>",
"        Expulsion (uncommon)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td rowspan=\"2\">",
"        1 ring monthly: cyclically (1 ring for 21 days, then 7-day ring-free interval) or continuously",
"       </td>",
"       <td>",
"        1-week \"window of forgiveness\"",
"       </td>",
"       <td>",
"        Uterovaginal prolapse or vaginal stenosis are relative contraindications",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Noncontraceptive benefits similar to those of oral contraceptive",
"       </td>",
"       <td>",
"        Risks: similar safety profile as that of oral contraceptive",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2_left\" colspan=\"6\">",
"        Progestin-only contraception",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" rowspan=\"3\">",
"        Progestin-only pill",
"       </td>",
"       <td>",
"        Contains norethindrone",
"       </td>",
"       <td rowspan=\"3\">",
"        <p>",
"         Perfect use: 99.7 percent",
"        </p>",
"        <p>",
"         Typical use: 92 percent",
"        </p>",
"       </td>",
"       <td>",
"        Effective and reversible",
"       </td>",
"       <td>",
"        Side effects: irregular bleeding; headache; bloating; acne; breast tenderness",
"       </td>",
"       <td rowspan=\"3\">",
"        Although often used by breast-feeding women, it may be used by any woman seeking reliable, reversible contraception",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Mechanism of action: cervical mucus changes; impaired sperm motility; possible inhibition of ovulation",
"       </td>",
"       <td rowspan=\"2\">",
"        Can be taken by women with contraindications to estrogen",
"       </td>",
"       <td rowspan=\"2\">",
"        Risks: no apparent increased risk of venous thromboembolism or cerebrovascular accident",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        1 pill daily: no pill-free interval; must be taken at same time every day (back-up method of contraception required if &gt;27 hours between pills)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: Fisher WA, Black A. Review: Contraception in Canada: a review of method choices, characteristics, adherence and approaches to counseling. CMAJ 2007; 176:953. Copyright &copy; 2007 Canadian Medical Association.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5486=[""].join("\n");
var outline_f5_22_5486=null;
var title_f5_22_5487="Gram stain lesion 1B answer";
var content_f5_22_5487=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F54920&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F54920&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Clostridium perfringens on blood agar",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 361px; height: 239px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Anaerobic culture of Clostridium perfringens on blood agar. The characteristic double zone of clear beta-hemolysis around a colony is clearly seen (arrow).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Harriet Provine.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f5_22_5487=[""].join("\n");
var outline_f5_22_5487=null;
